First Party Data

Part
01
of twenty-nine
Part
01

Concept of First Party Data

While gathering and using first-party data — that is, data that an organization has gathered from its own customers — is very common across most industries, it is far less common in healthcare due to the very tight constraints put on the use of personal health data by provisions like HIPAA in the US and the EU's GDPR.

FIRST-PARTY DATA DEFINITION

  • First-party data is information collected about a company or other organization's own customer base, e.g., purchase activity, website behavior, search terms used, etc.
  • It contrasts with third-party data, which pertains to people that the company has no preexisting relationship with, usually through companies which specialize in gathering and disseminating such data.
  • First-party data "is considered the most valuable, accurate and reliable data," in addition to having the benefit of being essentially without cost to collect.
  • Currently, momentum is shifting away from using third-party data, with "85% of brand marketers in the US and 75% of those in Western Europe" stating that increasing use of first-party data is a high priority in an April 2018 survey.

SOME WARNINGS ABOUT USING FIRST-PARTY DATA

  • Interestingly, while 80% of marketers make use of first-party data, there are two industries in which first-party data is not used for media targeting purposes: financial and healthcare.
  • Part of the reason may be that first-party data is subject to the data protection laws of the country the individual to whom it pertains resides in; for example, any company doing business with a customer in Europe is subject to the EU General Data Protection Regulation (GDPR) while any data pertaining to healthcare in the US must be kept in compliance with the Health Insurance Portability and Accountability Act (HIPAA).
  • In a healthcare context, it is particularly important not to send advertisements to potential prospects based on prior search patterns: "You never want to appear insensitive by reminding patients of their medical condition or make them feel tracked."
  • But more than that, it is actually illegal under HIPAA to use first-party data "to link known identifiable individuals to their medical conditions." In other words, a healthcare company can't use data that John Doe suffers from erectile dysfunction and use that information to directly market Viagra to him.
  • This is why many healthcare providers prefer to use third-party data to indirectly target potential customers.

GATHERING FIRST-PARTY DATA

  • First-party data "must be properly collected, cleaned, normalized, stored, analyzed and deployed through tech platforms" in order to be successfully used in a branding campaign.
  • A company should conduct a data audit to "understand the scale and depth of the first party data available." A data-poor company or marketer will need to supplement with third-party data.
  • However, collecting customer data requires patience and deftness: A recent survey shows that 35.9% of smartphone users will distrust a brand that asks for too much information about them.
  • In fact, 28% of customers distrust brands taking their personal data due to recent public data scandals.
  • It is less obtrusive to gather data "via tags on an advertiser’s digital assets" or by using cookies to track movement on the internet.

INTEGRATING DATA INTO A BRAND OR STRATEGY

Typical ad initiatives that use first-party data include:

Other findings on the use of first-party data in a company's branding strategy:
  • First-party data is best used with a customer-focused strategy rather than a product focused one.
  • Andy Monfried, founder and CEO of Lotame, a data management platform, agrees: "With first-party data, marketers are playing the long game. They are fostering an ongoing relationship with their customers and prospects by better communicating and serving them."
  • Consequently, it is often more effective to look for patterns, sometimes called "audiences" or "buyer personas," among a company's customers which "are much better described by their interests and attitudes" than simple demographic segments like gender, age, and geographic location, though these are also important to targeting an audience.
  • Most brands use a data management platform (DMP) to pull all of their customer and prospect data together, but this is not always needed up front; e.g., most demand side platforms (DSPs) have at least some data management functions built-in.
  • First-party data can be used to determine not only who became a customer of a particular product, but how that purchase journey ties back into what is already known about the customer's audience segment.

RESEARCH STRATEGY

We began our research by looking for a general overview of first-party data in order to ensure that we understood the concept properly. This led us to a recent series of articles from eMarketer which laid the foundation that we needed and provided many of the insights in our findings above.

Next, we researched how first-party data can be integrated into a company's brand or overall strategy, with a particular eye towards the healthcare and pharmaceutical industry. While it is nominally Wonder's practice to restrict ourselves to sources published within the last two years in order to ensure that we are providing our clients with the most up-to-date information available, in this case we made an exception: We found several articles written in 2019 which referenced a white paper published in 2016 on this very subject. Given that it is still being referenced today and that it provided a wealth of information on the topic (in fact, we recommend reading it in its entirety), we have included its valuable insights in this brief.
Part
02
of twenty-nine
Part
02

First Party Data - GSK

GSK has developed the MyQuit app and website that collects first party data. They have partnered on the flu tracker FluMoji, an allergy tracker and the MyAsthma app. They purchased a $300 million stake in 23andMe to access their genetic data.

GSK first part data information can be accessed here.

FIRST PARTY DATA USAGE, INVESTMENTS, & OWNERSHIP

  • GSK collects data from their website.
  • GSK has developed the MyQuit website and app to assist in smoking cessation.
  • GSK is working on transforming their global marketing operations to build personalized, analytics enhanced content for healthcare professionals.
  • GSK's brand TheraFlu created a Russian flu tracker app that used search, social input and weather data to identify areas with flu symptoms. It provided the brand with first party data to better target the media for flu related issues. It was more successful than their website attempts at the same thing.

FIRST PARTY DATA PARTNERING

  • GSK partnered with MIT to develop a flu tracker app, FluMoji, that collects data from users. It also has a social component and uses a crowd-sourcing component to collect data. It provides real time data.
  • GSK has partnered with The Weather Channel to develop an allergy tracker that has a personalized experience for the user.
  • GSK has partnered with the Nottingham Respiratory Research Unit to develop the MyAsthma app for asthma management. This app helps patients manage their symptoms by entering personal information and taking quizzes."

FIRST PARTY DATA BUYING

  • GSK has not bought any first party data.

FIRST PARTY DATA INVESTING

  • GSK has purchased a $300 million stake in 23andMe to access their genetic data. On 7/12/19, it was reported that 23andMe wants to begin collecting user's medical data by incorporating lab results, prescription information, and medical information,

FIRST PARTY DATA PATENTS

  • GSK has no first party data patents.

Research Strategy

To locate information on first party data, we first consulted GSK's website. We consulted their product and research pages to find relevant information. This approach did not give any usable research.

Next, we looked at their press releases and publications for the last several years. This gave us information on some of the apps they have developed.

Finally, we went to PRNewswire, Business Wire, and Tech Wire to see if there were any press releases involving GSK and data collection or first party data. This is where we located the bulk of our research on their apps, partnerships and investments.

We consulted Justia for the patent search and after screening all the patents, found no patents relevant to the criteria.


Part
03
of twenty-nine
Part
03

First Party Data - PARC

PARC is continuing to work on smart sensors to acquire data, amongst the topics listed were medical uses. They have developed algorithms to process data more efficiently. They have a patent for participatory sensing.

The requested details for PARC can be viewed in this spreadsheet.

USAGE, INVESTMENTS, INIATIAVES AND OWNERSHIP OF TECHNOLOGIES

  • PARC is developing smart sensors to acquire data. Medical data collecting is listed as a potential area.
  • They are developing algorithms to better process data from low quality sensors.
  • "At PARC, our team of data scientists applies statistical analysis and machine learning on both big and small data to reveal insights, make predictions and provide decision support."
  • PARC has developed peel and stick sensors to obtain data that are affordable.
  • People-Centric Urban Sensing focuses on collecting large amounts of information while protecting privacy and security.
  • "Participatory Sensing is an emerging computing paradigm that enables the distributed collection of data by self-selected participants. It allows the increasing number of mobile phone users to share local knowledge acquired by their sensor-equipped devices, e.g., to monitor temperature, pollution level or consumer pricing information."

FIRST PARTY DATA PARTNERING

  • In 2015, they partnered with LeanTaaS Inc., to work on machine learning algorithms to process big data.

FIRST PARTY DATA BUYING

  • PARC does not participate in first party data buying.

FIRST PARTY DATA INVESTING

  • PARC does not invest in any areas involving first party data.

FIRST PARTY DATA PATENTS

  • A system to manage patient parameters provided by monitoring devices was patented in 2014. There are two patents involved with this system.

Research Strategy

To locate information on first party data, we first consulted PARC's website. We consulted their competency areas of AI, Human Machine Collaboration, IoT & Machine Intelligence, Digital Design & Manufacturing, Microsystems & Smart Devices, Novel Printing, and Digital Workplace to find relevant first party data information. Upon researching all the areas, we were able to locate technologies they are working on in the area of data collection. We have included them in our findings. We also looked at their specialty section on Data Science and found relevant information,

Next, we looked at their press releases and publications for the last twenty years. Again, we included any relevant information.

Finally, we went to PRNewswire, Business Wire, and Tech Wire to see if there were any press releases involving PARC and data collection or first party data. There were no relevant results.

PARC focuses on technologies and systems to collect data rather than using significant amounts of first party data. This is most likely the reason we did not find any information during the research process that regarded buying or investing in first party data related areas.

Part
04
of twenty-nine
Part
04

First Party Data - Pfizer

Pfizer collects first part data with their website. Quitter's Circle and an app for cancer patients are also used to collect first party data. They have collaborated with Concerto HealthAI to get first party data from physicians that are treating cancer patients. They have also collaborated with 23andMe to gain access their first party data.

First party data information for Pfizer can be accessed here.

FIRST PARTY DATA USGE, INITIATIVES & OWNERSHIP OF TECHNOLOGIES

  • Pfizer uses mobile apps to collect personal data. They also use surveys within the apps. They collect first party data on their website through registrations, applications and purchases.
  • Quitter's Circle is an app to assist with smoking cessation. There is a social component to this app.
  • Pfizer has an app for cancer patients. Along with collecting personal information and cancer type, the patient can enter appointments, reminders, notes, insurance information, information from their personal calendar, and connect it to a wearable activity tracker. Data is collected from the activity tracker and sent to make calculations that are then displayed in the app. "

FIRST PARTY DATA PARTNERING

  • Pfizer collaborates with Concerto HealthAI. They use real world data to advance the study of oncology. This data is collected from clinical practices.
  • Pfizer has collaborated with 23andMe to use their first party data for research. "

FIRST PARTY DATA BUYING

  • Pfizer does not participate in first party data buying.

FIRST PARTY DATA INVESTING

  • Pfizer does not participate in first party data investing.

FIRST PARTY DATA PATENTS FILED

  • Pfizer has filed no patents related to first part data.

RESEARCH STRATEGY

To locate information on first party data, we first consulted Pfizer's website. We researched their prescription and over the counter medications. Through this research we discovered their mobile apps and their privacy policy which disclosed how they collected information.

Next, we looked at their press releases and publications from their website. These were focused on medicines that were in progress or that had been introduced.

Finally, we went to PRNewswire, Business Wire, and Tech Wire to see if there were any press releases involving Pfizer and data collection or first party data. This method led us to more information pertaining to the apps they use along with the companies they have collaborated with.

In conducting a patent search we only found medicine related patents.

During our research we did find an article that discussed how HIPPA laws affect pharmaceutical companies and how they can use first party information. There are very strict laws regarding this. For example, they can not use any data they obtain and use it to show advertisements while you are visiting a web page. Pharmaceutical companies are also restricted as to how they can follow people around on the web due to these regulations.
Part
05
of twenty-nine
Part
05

First Party Data - Merck

Merck has little published involvement with first party data. They have developed an app for consumers, and two other apps in a partnership with Geisenger. The recently acquired the company MedHelp, a health app developer.

First party data information for Merck can be accessed here.

FIRST PARTY DATA USAGE, INITIATIVESM & TECHNOLOGIES

  • Merck uses their website to collect first party data.
  • Merck developed the C2Day Consumer app, but very little information was available and it was not available for download. On the Privacy notice for this app, Merck stated all information was stored locally and not shared with them.

FIRST PARTY DATA PARTNERING

  • Merck collaborated with Geiseinger to develop two different programs to boost medications adherence and to connect patients with providers. More information will be available this year. The app Family Caregiver enables two-way communication between caregivers and medical care teams. The second app, MedTrue, which draws medication data from multiple sources to create a medicine list and help with adherence.

FIRST PARTY DATA BUYING

  • Merck does not engage in first party data buying.

FIRST PARTY DATA INVESTING

  • Merck's subsidiary acquired the app maker MedHelp for an undisclosed amount. Some of the apps involved are Sugar Sense, Mty Diet Diary, and I'm Expecting, along with My Cycles (for women).

FIRST PARTY DATA PATENTS

  • Merck has no patents related to first party data.

Research Strategy


To locate information on first party data, we first consulted Merck's website.

Next, we looked at their press releases and publications for the last several years. Again, we included any relevant information. We researched the Healthy Living page, the product list, R&D, and their focus areas of diabetes, oncology, and vaccines. We further researched their inventions, patient assistance, "Helping the Word Be Well", and Merck Mobile apps to find any evidence of first party data usage. The results are presented in our key findings.

Finally, we went to PRNewswire, Business Wire, and Tech Wire, and the American Medical Association to see if there were any press releases involving Merck and data collection or first party data. With this research we were able to find information on their collaborations and an acquisition.

During our research we did uncover a job advertisement for a marketing lead to deal specifically with first, second, and third party data.

When researching patents, we went to Merck's list and found nothing that pertained to our research. To make sure, we searched on Justia. Again, we found no patents relating to the research.


Part
06
of twenty-nine
Part
06

First Party Data - AmGen

Our research indicates that Amgen has engaged in four first party data-related initiatives in recent years, in addition to three partnerships in this area. However, we did not find any evidence that Amgen has acquired, or invested in, any companies focused on first party data, nor filed any patents in this space. Our findings have been entered in the attached spreadsheet, and can also be found below, followed by an explanation of our research methodology.

Findings

  • Amgen is currently utilizing "data and analytics to explore how healthcare providers and patients interact with our products, how they could be improved, what we might learn from an access standpoint, and what factors are contributing to appropriate adherence."
  • Amgen has instituted a Supplier Relationship Excellence (SRE) "to open the lines of communication with suppliers and create a feedback loop where data can be shared to better understand operational performance." One example of data exchanged via this SRE is the approximately 200,000 daily first party data points generated via "robotics-based drug candidate screenings."
  • Amgen created "an in-house, validated information system, called Raw Material Information System (RMIS), where we could document and store raw material data," such as the aforementioned drug candidate screening data.
  • To standardize the file format within the RMIS, Amgen developed "a data file format based on scientific data exchange technologies" that eventually "became a published standard that can be used as a reference guide for eData exchange."
  • deCODE Genetics, a wholly-owned subsidiary of Amgen, is partnering with Intermountain Healthcare to execute the "HerediGene: Population Study, [which] represents the largest and most comprehensive DNA mapping effort to date in the United States from a single population." The study is utilizing Intermountain first party data collected from 500,000 of its patients.
  • Amgen partnered with Deloitte and Qlik to produce a cloud-based data platform called the Translation Research Information Platform (TRIP), which enables "a whole range of new possibilities for using clinical trial data."
  • Amgen has partnered with Humana to utilize the latter's first party data from its insurance customers to combat various diseases, "combining information from existing data sources with data from wearable technologies and digital health apps."

Your research team employed the following strategy:

To determine if Amgen is involved with first party data, and, if so, the extent of that involvement, we first conducted an extensive search of company-provided materials. This included an exhaustive search of all the company's press releases for the past two years, stored on the company's online news archive. It also included a search of various investor relations materials, including the company's 2018, 2017, and 2016 annual reports. This produced some information regarding first party data gathering activity and initiatives. Still, we continued the research to determine if Amgen's involvement in this area extended any further.

As a second approach, we conducted a search of third-party databases, hoping to find evidence of first party data technologies, partnerships, purchases, investments, or patents that Amgen developed, sought or obtained. For example, we conducted a search of patent databases such as Google Patents to determine if Amgen sought and/or obtained any patents in this area. We also conducted a search of marketing campaign case study databases, such as Effie, hoping to find an Amgen campaign which demonstrated some use of first party data. From this method, we did not find any additional information, demonstrating that Amgen does not appear to have filed any patents related to first party data, or made public its use of such data in marketing.

As a third approach, we conducted a wide-ranging press search, hoping to find reporting from third-party media outlets regarding any involvement by Amgen with first party data. This search included outlets focused on pharmaceutical industry generally as well as pharmaceutical marketing in particular, in addition to general business-focused outlets like Forbes and general interest outlets like The New York Times. This produced some additional information, although still did not indicate that Amgen has filed any patents with regard to first party data, or made any investments or purchases in this space. As such, we indicated 'no' in the relevant cells of the attached spreadsheet.
Part
07
of twenty-nine
Part
07

First Party Data - Eli Lilly

After an extensive search of Eli Lilly's company materials as well as third-party databases and media outlets, we found only two connections between Eli Lilly and first party data in the public domain. It is possible that the company's involvement with first party data is simply limited at this time, or that much of its involvement remains outside of the public domain. In any case, we have entered our findings in the attached spreadsheet; these findings can also be found below, followed by an explanation of our research methodology.

Findings

  • V. Gopal, who has been Eli Lilly's chief data and analytics officer for just over a year now, is putting an increased effort on data analytics, "bringing advanced capabilities such as artificial intelligence, machine learning, and predictive analytics to address pertinent business questions in various functions at Lilly."
  • Eli Lilly is expanding its preexisting collaboration with Evidation to give the former "access to Evidation's data platform with the goal of uncovering new ways to measure and understand a patient's health by accessing consented data derived from smartphones, connected sensors, wearables, and even his or her own voice."

Your research team employed the following strategy:

To determine if Eli Lilly is involved with first party data, and, if so, the extent of that involvement, we first conducted an extensive search of company-provided materials. This included an exhaustive search of the company's press releases in the last two years, found on its online press release archive. It also included a search of the company's investor relations materials, including its 2018, 2017, and 2016 annual reports. This search did reveal a recent data-driven partnership with Evidation, but did not indicate any further involvement with first party data technologies or companies.

As a second research approach, we conducted a search of third-party databases, hoping to find evidence of Eli Lilly's involvement with first party data. For example, we searched Google Patents to determine if the company had filed any patents related to first party data. Additionally, we searched marketing campaign case study databases such as Effie to see if there was any evidence that Eli Lilly had conducted any marketing campaigns that utilized first party data. However, no additional information was found, suggesting that Eli Lilly has not filed any first party data-related patents, nor publicly discussed any first party data-related marketing efforts.

As a third approach, we conducted a wide-ranging press search, hoping to find reporting from third-party media outlets regarding any involvement by Eli Lilly with first party data. This search included outlets focused on pharmaceutical industry generally as well as pharmaceutical marketing in particular, in addition to general business-focused outlets like Forbes and general interest outlets like The New York Times. This revealed that Lilly's recently-appointed chief data and analytics officer, has brought a new focus to the company with regard to advanced data analytics, although no specific initiatives or investments in this regard were found.

After conducting these three approaches, we found only one partnership between Eli Lilly and another company with regard to first party data, and no specific use cases, investments, or initiatives within the company, nor any acquisitions of or investments in companies focused on first party data, nor any patents filed in this space. It is possible that Eli Lilly's involvement with first party data is simply limited at this time, or that much of its involvement is kept private. In any case, we entered 'no' in the relevant cells of the attached spreadsheet to indicate that little data in this regard was available in the public domain.
Part
08
of twenty-nine
Part
08

First Party Data - Novartis

Our research indicates that Novartis has engaged in five distinct first party data-related initiatives in recent years, in addition to one partnership in this respect (this is excluding activity related specifically to third party data, such as the company's recent partnership with Oxford). However, we did not find any evidence that Novartis has acquired, or invested in, any companies focused on first party data, nor filed any patents in this space. Our findings have been entered in the attached spreadsheet, and can also be found below, followed by an explanation of our research methodology.

Findings

  • Novartis's Predictive Analytics & Design Group is pioneering a platform called Nerve Live. This platform "uses the latest advances in computing technology and is designed to help Novartis leverage its huge data pool."
  • Novartis is using machine learning to sift through cellular data and assist in the development of new drugs and therapies.
  • Novartis's Trial Footprint Optimizer helps company officials plan first party data collection via clinical trials. The module helps "plan and simulate country allocation scenarios for clinical studies, such as choosing the best sites, tracking enrollment, and predicting patient enrollment curves."
  • Novartis has recently launched a clinical trial 'control tower' module called Sense that allows company officials to evaluate data collection via clinical trials from "a central room equipped with large wall screens and dedicated workstations."
  • Novartis's Global Drug Development (GDD) department recently undertook an initiative called Systematic Transformation Initiative for Development Excellence, or STRIDE. The goal was to institute new infrastructure that made accessing and utilizing data easier, such as "a number of new systems, including a brand-new submission and document management system, a brand new investigative portal, a brand new high-performance computing environment, and a new clinical trial management system (CTMS)."
  • Novartis is partnering with Verily, an Alphabet subsidiary, on the latter's 'Project Baseline.' This project is a digital research platform that is intended "to increase the number and diversity of study populations by making it easier for participants to enroll and contribute their health data."

Your research team employed the following strategy:

To determine if Novartis is involved with first party data, and, if so, the extent of that involvement, we first conducted an extensive search of company-provided materials. This included an exhaustive search of all the company's press releases for the past two years, stored on the company's online news archive. It also included a search of various investor relations materials, including the company's 2018, 2017, and 2016 annual reports. This produced some information regarding first party data gathering activity and initiatives. Still, we continued the research to determine if Novartis's involvement in this area extended any further.

As a second approach, we conducted a search of third-party databases, hoping to find evidence of first party data technologies, partnerships, purchases, investments, or patents that Novartis developed, sought or obtained. For example, we conducted a search of patent databases such as Google Patents to determine if Novartis sought and/or obtained any patents in this area. We also conducted a search of marketing campaign case study databases, such as Effie, hoping to find a Novartis campaign which demonstrated some use of first party data. From this method, we did not find any additional information, demonstrating that Novartis does not appear to have filed any patents related to first party data, or made public its use of such data in marketing.

As a third approach, we conducted a wide-ranging press search, hoping to find reporting from third-party media outlets regarding any involvement by Novartis with first party data. This search included outlets focused on pharmaceutical industry generally as well as pharmaceutical marketing in particular, in addition to general business-focused outlets like Forbes and general interest outlets like The New York Times. This produced some additional information, although still did not indicate that Novartis has filed any patents with regard to first party data, or made any investments or purchases in this space. As such, we indicated 'no' in the relevant cells of the attached spreadsheet.
Part
09
of twenty-nine
Part
09

First Party Data - Sanofi

Our research indicates that Sanofi currently has one first party data-related initiative within the company and three external partnerships involving first party data. Additionally, the company has filed one recent patent involving the collection of first party data, although it has not invested in, or purchased, any companies focused on first party data. Our findings have been added to the attached spreadsheet, and can also be found below, followed by an explanation of our research strategy.

Findings

  • Sanofi is utilizing AI-based natural language processing (NLP) to interpret textual data in conjunction with drug development, and has already done so "as part of its multiple sclerosis (MS) drug biomarker project."
  • Sanofi is partnering with Google to leverage Sanofi's first party data using "Google’s industry-leading capabilities, from cloud computing to state-of-the-art artificial intelligence."
  • Sanofi is partnering with Verily, an Alphabet subsidiary, on the latter's 'Project Baseline.' This project is a digital research platform that is intended "to increase the number and diversity of study populations by making it easier for participants to enroll and contribute their health data."
  • Sanofi partnered with Evidation to use the latter's "behavioral data analysis platform, Real Life Study, for work that will be powered with data collected from wearables and mobile applications."
  • Sanofi recently filed a patent for "a data collection device for attachment to an injection device and for collecting medicament dosage information therefrom" (such information would be first party data).

Your research team employed the following strategy:

To determine if Sanofi is involved with first party data, and, if so, the extent of that involvement, we first conducted an extensive search of company-provided materials. This included an exhaustive search of all the company's press releases for the past two years, stored on the company's online news archive. It also included a search of various investor relations materials, including the company's 2018, 2017, and 2016 annual reports. This produced information regarding Sanofi's first party data-related partnership with Google, but no other relevant findings. As such, we continued the research to determine if Sanofi's involvement in this area extended any further.

As a second approach, we conducted a search of third-party databases, hoping to find evidence of first party data technologies, partnerships, purchases, investments, or patents that Sanofi developed, sought or obtained. For example, we conducted a search of patent databases such as Google Patents to determine if Sanofi sought and/or obtained any patents in this area. We also conducted a search of marketing campaign case study databases, such as Effie, hoping to find a Sanofi campaign which demonstrated some use of first party data. From this method, we determined that Sanofi has filed one recent patent that directly relates to the collection of first party data, though it does not appear to use such data in marketing (or at least has not made such use publicly known).

As a third approach, we conducted a wide-ranging press search, hoping to find reporting from third-party media outlets regarding any involvement by Sanofi with first party data. This search included outlets focused on pharmaceutical industry generally as well as pharmaceutical marketing in particular, in addition to general business-focused outlets like Forbes and general interest outlets like The New York Times. This produced some additional information, although still did not indicate that Sanofi has made any investments or purchases in this space. As such, we indicated 'no' in the relevant cells of the attached spreadsheet.
Part
10
of twenty-nine
Part
10

MaaP and First Party Data

Mouth as a Platform is currently being used to obtain first party data in some instances. IQ Group Global, Glucose Biosensor Systems Holdings, Glucema, NEPeSMO, MX3, DNA Nudge, Home X Code, Prenetics, Ancestry DNA, 23andMe, and Everly Well all collect first party data.

FIRST PARTY DATA DEFINITION

  • First party data is the data collected about your audience through paths that you directly own or manage. For this research, we will look at unique first party data collected beyond basic information such as name, e-mail, age, gender, and other identifying information the user provides.

MaaP FIRST PARTY DATA IMMEDIATELY OBTAINED THROUGH SMARTPHONE OR OTHER DEVICE

  • iQ Group Global has designed a pea sized MaaP sensor that will check glucose levels. The information is then beamed from the sensor to a smartphone. The information is stored to display trends in glucose levels. They are currently developing data sharing capabilities in the app itself. This technology is still in development and has not been released for the public. The first party data collected is glucose levels.
  • Similarly, Glucose Biosensor Systems Holdings, has developed a MaaP technology test that read glucose levels. When the biosensor is near a phone it will upload information. The app will flag results that need attention and provide real time information for medical records and caregivers. The first party data collected is glucose levels.
  • Glucema also measures glucose levels and uploads them by the use of a hand held reader. This information can be transferred to their mobile app. The first party data collected is glucose levels.
  • NEPeSMO uses MaaP technology to remotely monitor and prevent lung attacks. The information is transmitted to the app via a wireless monitoring device on the user. The first party data collected are the bio markers in the saliva that indicate lung issues.
  • MX3 has developed a device that uses strips to detect hydration levels and makes recommendations. This information is stored by the company to monitor trends and make recommendations. The first party data collected is hydration levels from saliva.

MaaP FIRST PARTY DATA OBTAINED BY SENDING FOR ANALYSIS

  • DNA Nudge takes a saliva swab from the user and analyzes it. Then, they recommend food that is compatible with one's metabolism. The first party data collected is DNA.
  • Home X Code, Prenetics, Ancestry DNA, and 23andMe all provide DNA analysis upon the user send in the saliva sample. The first party data collected in DNA.
  • Everly Well conducts over 30 tests by sending the user an at home kit. The first party data collected is a wide variety of bio markers for diseases and conditions.

MaaP DATA COLLECTED ONSITE (NOT NECESSARILY BECOMING FIRST PARTY DATA UNLESS IT IS REPORTED BY CLINICIAN OR PATIENT)

  • A variety of diseases and levels can be detected through MaaP. These are normally done in a clinical setting or in the privacy of one's home. This information is not necessarily reported or used as first party data unless the clinician or patient chooses to do so. This method makes up the bulk of MaaP technologies. They include:
  • Salvary liquid biopsies are used to detect tumor cells in a non-invasive manner.
  • A miniature lab on a chip is being developed to detect disease by MaaP including, hormone related, HIV, and alcohol testing.
  • MaaP can detect glucose levels, illegal drugs, HIV, periodontal disease, heart disease, cholesterol, cancers, oral health related diseases, HPV risk, Hepatitis C, Influenza, fertility issues, gout, and fatty liver disease.
  • Maap is being developed to test for concussion recovery and malaria.

Synthesis

  • Much MaaP technology is currently used for at home or in a clinical setting with no data reporting. Various forms of DNA collection are quite popular. Technologies that incorporate MaaP technology with any form of real time reporting hold the smallest share of MaaP technologies.
Part
11
of twenty-nine
Part
11

Vertical Health Platform Concept

The use of apps and devices to track and attend to individual patient health, known as mHealth, is popular in concept and mHealth apps outperform other apps in terms of annual downloads by far. However, there is an open question of how helpful these apps really are, leading to calls for more rigorous testing and even regulation, either or both of which could shake up the market.


THE EHEALTH AND MHEALTH MARKET


BEST THERAPY FIELDS FOR EHEALTH

The therapy fields with the best market conditions for eHealth solutions are currently believed to be:


However, debate remains about which fields will have the best market conditions going forward as all fields, save depression, have seen a gradual decrease in successful apps in the last four years.

DISRUPTIVE EHEALTH AND MHEALTH TECHNOLOGIES

According to eHealth publishers the most disruptive technologies on the horizon are:

  • Artificial Intelligence (61%)
  • Remote monitoring and assistance (43%)
  • Wearables (34%)
  • IoT (30%)
  • Virtual Reality (27%)
  • 3D Printing (22%)
  • Blockchain (18%)

Notably, successful publishers express similar sentiments to publishers generally except that they are far less impressed with wearables.

QUESTIONS ABOUT EFFICACITY

Despite a generally bullish market for mHealth, there are those who question the efficacy of such apps, which may become important if indeed insurers continue to be the distribution channel of choice.


RESEARCH STRATEGY

We began our research by conducting a broad-based search in both academic and lay healthcare resources on the topics of eHealth and mHealth (mHealth being the subset of eHealth which pertains to the use of mobile devices, including smartphones, tablets, and wearables). This led us to a current "discussion" being held within the healthcare community about the efficacy of mHealth platforms, which contributed to our findings above.

While that discussion is indeed important to understand how the mHealth industry is developing, it is not the whole picture. As we broadened our search, we found a number of articles which cited a 2017 study of mHealth economics by Research2Guidence. While pushing the limits of our nominal 2-year cutoff for sources, it was the most comprehensive study of its kind, and we found no other more recent source comparable to it. The study, therefore, became a backbone of this brief as well as a guide to the rest of our research.
Part
12
of twenty-nine
Part
12

Vertical Health Platforms and First Party Data

Of the two vertical health platforms addressed in the previous research, eHealth first-party data is most often entered by the medical staff. On the other hand, mHealth first-party data is primarily collected from the person who is using the app, either for personal data management or for sharing information with a health team.

OVERVIEW

  • The two concepts addressed in the previous research are eHealth and mHealth.
  • eHealth is defined as using electronic health records, while mHealth is defined as using health applications on mobile and other devices.

1) eHEALTH

ELECTRONIC HEALTH RECORDS
  • Electronic Health Records (EHR) systems are usually implemented with manual records from the doctor's office.
  • Once the system is operational, first-party data is given by the patient to the clinical team and/or office staff, who enters it into the EHR.

TELEMEDICINE
  • There has been a recent increase in the use of telemedicine, especially by health care consumers.
  • In these platforms, the patients create an account and enter all of their demographic data and any medical history they think is relevant.
  • Once they are connected with a doctor, the doctor then becomes the person responsible for entering the first-party data for the diagnoses and treatment.
  • An example of this is Amwell.

AMWELL
  • Amwell is an app available for download for use on a computer, a tablet or a smartphone. It provides access to a certified doctor online for diagnosis and treatment of a set of over 100 conditions from acid reflux to the zika virus.
  • When the patient signs up for an account, first-party information is collected directly from the patient. It includes demographics, location, medical history, and current symptoms.
  • Once the patient and the doctor have connected, the patients' record is updated by the doctor with diagnoses and treatment, as well as referral information.
  • Amwell stores all of this personal information in their database(s).

2) mHEALTH

  • mHealth pertains to the use of applications on mobile devices that support health management.
  • In general, the initiation of the use of these applications resides with the patient.
  • The patient, therefore, becomes the primary person who enters first-party data into the application.
  • The ownership of the app, and therefore the data, is not always clear.

TYPES OF mHEALTH APPLICATIONS

A. Sole Use
  • The first type is used solely by the customer/patient to track their personal health information. They enter the first-party data and, while it is stored on a server managed by the app developer, it is officially "the patient's data".
  • An example of that kind of app is "My Calendar Period Tracker", which is designed to help women keep track of periods, cycle, ovulation, and fertile days.
  • It can be used by those who are concerned about conceiving, birth control, contraception, or regularity of period cycles.
  • The tracker enables users to track irregular periods, weight, temperature, moods, blood flow, symptoms, and more.
  • First-party data from this app includes period start and end dates, as well as all the above fields.
  • The data is stored on Apple servers.
  • As stated in the previous research, there are no regulations specifically for mHealth applications.
  • Apple guarantees the privacy of the client data because of its platform.

B. Personal Health Management Through Data Sharing
  • The other type of mHealth application involves the ongoing sharing of information. Some of these applications state they are HIPAA compliant.
  • BlueStar is an example of that model. The patient enters their name, location, demographic data, and all monitoring data collected and entered by users, including daily blood sugar readings and regular A1C results.
  • It is only available by prescription, and the software provides summarized data and analytics to a patient’s providers.
  • Although it is rated as HIPAA compliant, the term provider could include not just the health care team but also the insurance company.

CONCLUSION

Except for EHRs in doctor's offices and hospitals where clinicians enter first-party data, in both the current telemedicine and mHealth applications downloaded by customers, the patient/customer is the party that provides the first party data.

Part
13
of twenty-nine
Part
13

Illness Tracking Platform Concept

While experts see immense potential in using apps and websites to track community health issues and illnesses, at present neither the data quality nor the level of our machine learning technology is in a position to produce reliable results. While community health tracking sites do exist, they still curate their data from news sources using decades-old techniques, and GlaxoSmithKline's (GSK) Watson-powered flu-tracker remains a singular example of a cutting-edge disease tracking app.

THE POTENTIAL TO BUILD ADVANCED MODELS

  • While the wide spectrum of eHealth devices means that it is now possible to harvest sophisticated biometric information from a wide range of people, e.g., "from home athletes to chronic healthcare patients."
  • A recent study on the use of eHealth in pharmacies concludes that pharmacists can use apps to perform a range of functions, including keeping on top of disease states and maintaining adequate inventories of medications.
  • The incredible volume and complexity of the data being collected by mHealth apps and devices will necessitate the development of machine learning and AI to analyze, use, interpret, and integrate this diverse health data.
  • Machine learning is expected to develop models which will predict the occurrence of diseases in particular sub-populations; this type of modeling of the flu was announced by GlaxoSmithKline (GSK) in late 2016, which used IBM's Watson to analyze the data.
  • GSK later sponsored an app "designed to promote awareness of flu spread and symptoms as well as provide educational materials" to the public.
  • While several white papers have been published promoting the development of AI to track public health issues similarly to the flu tracker (and the earlier version created by Google in 2010), a thorough search of both healthcare and tech news sources and academic works did not provide examples of apps developed for other diseases or health concerns.

THE NEED FOR BETTER DATA

  • Developing accurate models for predicting and tracking community health issues is dependent on having good, clean data.
  • Data quality from mHealth devices has been problematic in this regard, often being "incomplete, inaccurate, and collected over too short a duration" to be useful for advanced analysis.
  • Even papers written in 2019 acknowledge that the use of patient generated data (PGD) has focused "on sickness rather than wellness issues," which is to say, on treating present patients of illness individually rather than using the aggregate data to proactively track community health issues.

SECURITY CONCERNS

  • In addition to security risks in the transmission of sensitive health information from mHealth devices, experts have expressed concern about "a potential risk of misuse [of the data] via patient profiling."
  • Blockchain technology, which is tamper-proof and able to be used across a wide range of otherwise incompatible systems, may provide future physicians a single, secure database of aggregate health records derived from eHealth and mHealth platforms.

RESEARCH STRATEGY

We began our research by studying academic papers, mostly literature reviews of multiple studies, to determine how eHealth and mHealth apps and devices are currently being used and tested for use in tracking illnesses at the population level and community health issues. In each case, we made use of Google's Scholar database, which enables us to track the thread of citations in order to locate the most recent information available. In many cases, the most recent articles were available only in abstract, but as the project criteria requests concepts and developments rather than hard, quantitative data, these were often sufficient for our purposes.

While this gave us a sufficient understanding of the challenges faced in collecting and analyzing sufficient data from websites and apps to track community-level health issues (explained in our findings above), we were concerned about the lack of concrete examples of apps and websites which do so.

Since tracking the flu was specifically mentioned as an example, we pulled the history behind GSK's AI-assisted flu tracker (launched in 2016, with an app developed for the public in 2017). Since that was considered a breakthrough example at the time (as well as something of a marketing coup), we looked for announcements of apps and websites which either used similar language to describe them or outright cited the GSK flu tracker as an inspiration. Both this, and a general search of trusted news organizations, failed to yield any examples. We hypothesize that this is due to the difficulties of obtaining and analyzing health data as explained in our findings above.

This is not to say that there are no community health tracking apps. However, these, like Healthmap, use news aggregation techniques to monitor outbreaks that have changed little since 2006. Others make use of databases like Google Trends using methodologies that we find documented to at least 2010. As such, they hardly fit the criteria of being new developments.

In short, experts are enthusiastic about the possibility of curating patient data through eHealth and mHealth devices, apps, and websites and using that aggregate data to track and even predict community-level health issues. However, we are very much in the early days of the technology and neither the quality of the data nor the development of the necessary machine learning is yet at the level needed for the next big breakthrough.
Part
14
of twenty-nine
Part
14

Illness Tracker Platforms and First Party Data

Doctors Report, My Quit, My Asthma, Cancer LinQ, Living With, Med True & Family Caregiver, eCare 21, Lyme Symptom Tracker, and Flaredown all collect first party data. eCare 21 is the only app to collect and monitor medical data(blood pressure, glucose, etc.) that is obtained directly from the patient.

DOCTORS REPORT ILLNESS TRACKER

  • This app lets the user check how often doctors have reported 15 different diseases within a zip code.
  • Reports are generated from over 900,000 doctor's office.
  • The app works by grabbing the first party data as the physician reports it to the payor.

MY QUIT

  • This app assists the user with smoking cessation.
  • The user enters cravings and triggers.
  • They are able to select a quit date and nicotine replacement preference.
  • The app collects personally identifiable information like name, address, telephone number, and email address along with the information about cravings and triggers.
  • The information is used to respond to requests, improve service, improve content, notify the user of new products, and to seek views on products and services.

MY ASTHMA

  • MyAsthma helps patients manage their asthma by letting them track their condition.
  • This app can also be used by caregivers.
  • The app captures environmental data that lets the users analyze the factors that trigger their asthma.
  • Users can access a test that lets them monitor their asthma control monthly.
  • The app collects personally identifiable information along with the triggers.

CANCER LINQ

  • Pfizer has collaborated with HealthAI to present Cancer LinQ.
  • This is one of the most " comprehensive real-world data sets available from Concerto."
  • The goal of this project is to obtain patient insights for oncology work by using patient data.
  • The app collects patient data for analysis to find new cancer treatments.

LIVING WITH

  • This app is for cancer patients and caregivers to manage the disease.
  • The app has a social component to update interested friends and family.
  • There is a dashboard to manage daily tasks with the ability to coordinate assistance from family and friends.
  • Documents related to treatment can be stored.
  • It has tracking tools for mood, pain, steps, and sleep.
  • The app collects the personal data the user chooses to provide such as email, cancer type, symptoms, medications, appointments, reminders, notes, recordings from physicians, calendar, and activity information from activity tracker.

eCARE 21

  • eCare 21 is a remote patient monitoring system for medical providers.
  • It enables caregivers and healthcare professionals to monitor patients remotely by integrating with FDA-cleared devices to collect "blood pressure, blood glucose, weight & SP02 along with self-reported medication compliance and symptoms."
  • It has a mobile app and platform and is 100% HIIPA compliant.

MED TRUE & FAMILY CAREGIVER

  • This is a collaboration between Merck & Geisinger. The apps are yet to go to market. They are expected to see results by the second quarter of 2019.
  • These apps are electronic healthcare record friendly. The goal of both apps is to reduce drug errors and keep patients and providers connected.
  • Med True integrates medication data from multiple sources to provide verified lists of medications for patients. The app will collect data such as prescription fills and medication lists.
  • Family Caregiver essentially does the same as Med True, but has caregiver friendly modifications like a calendar that is accessible to the healthcare professionals. It gathers information from the various providers involved with the patient.
  • This app collects personal data along with the medical data.
  • It is embedded within the electronic medical record (EMR).

LYME SYMPTOM TRACKER

  • The Lyme Symtpom Tracker is a digital health platform that uses patent centric data collection.
  • The goal is to use the information to increase patient access to experimental treatments and use crowdsourcing to solve Lyme diseases.
  • Patients can track their symptoms and share data with their healthcare providers along with connecting to a clinical trial.
  • The app uses Appbakery, a do it yourself platform. It creates mobile data tracking apps.

FLAREDOWN

  • Flaredown is a comprehensive symptom tracker.
  • This app lets you track foods, medications, natural treatments, mental health, mood, weather, exercise, and sleep. If the app does not track the required "symptom", the user may add it.
  • Flaredown checks in with the user daily to gather the information the patient wants to record.
  • The user may share this information with doctors, family, and friends.
  • Flaredown uses the data to help the patient find out what triggers episodes and to better target treatments.
  • The data in also made anonymous and shared with scientists and researchers.
  • Flaredown supports all conditions.

Analysis

  • The majority of apps researched only are trackers of information provided by the user. Rarely do they do anything with the information beyond synthesis. When the apps do share information, it is primarily to healthcare professionals to coordinate better care. The only platform that actually collected patient's data (blood pressure, glucose, etc.) was developed by a company that deals with Medicare and Medicaid billing to create more billable hours. There seems to be a lack of any apps that collect actual data beyond patient entered data.

Research Strategy

We first collected data on the first party data apps that were discovered in previous research. After analysis, the results did not seem robust enough to show the entire picture. We expanded our research to apps found on Google Play and the Apple App Store to get a better perspective and possibly find apps that did more than just collect what the user shared.
Part
15
of twenty-nine
Part
15

Vertical Health Emerging Tech 1

Some companies developing platforms or technologies that are designed to track, monitor, assist, and/or are specialized to deal with certain types of health issues include Medasense Biometrics Ltd, Your.MD, Sensely, SkinVision, Healint, Lunit Inc., Cyrcadia Health, FibroMapp, MoxyTech and Managinglife.com.

Medasense Biometrics Ltd

  • Company name: Medasense Biometrics Ltd
  • Website linked here.
  • Technologies in development: the PMD-200™, is a monitoring device that quantifies patients’ physiological response to pain. "Medasense develops innovative systems and applications to objectively assess the physiological response to pain, providing insight throughout the pain management process for accurate and personalized pain care."
  • Partnerships in place: none

Your.MD

  • Company name: Your.MD
  • Website linked here.
  • Technologies in development: the company currently has the symptom checker which is able to calculate headaches, migraines, Irritable Bowel Syndrome (IBS), constipation, common colds, flu, sore throat, depression, anxiety, skin irritations & disorders, hay fever, osteoarthritis, back pain, allergies, lactose intolerance, etc.
  • Partnerships: BMJ Best Practice

Sensely

SkinVision

Healint

  • Name: Healint
  • Website linked here.
  • Technology in development: Healint has developed a product called Migraine Buddy, this app is known as the best migraine app in the world. Clients are able to track their migraine, understand their triggers, and share their migraine history with their doctor to get the best possible treatment.
  • Partnerships in place: none

Lunit Inc.

Cyrcadia Health

  • Name: Cyrcadia Health
  • Website linked here.
  • Technology in development: the company has developed a "novel breast health screening device and methodology based on disruptive technology and tissue health science. " This helps clients to track breast cancer.
  • Partnerships in place: none

FibroMapp

  • Name: FibroMapp
  • Website linked here.
  • Technology: the company developed an app called FibroMapp Pain Manager. The app is used to manage fibromyalgia and for chronic pain self-management.
  • Partnerships in place: none

MoxyTech

Managing life

  • Name: Managing Life
  • Website linked here.
  • Technology in development: Managing Life has developed an app called Manage My Pain. The app helps patients to track and analyze their pain and also share it with the doctor.
  • Partnerships in place: none
Part
16
of twenty-nine
Part
16

Vertical Health Tech 2

Information regarding companies developing platforms or technologies, which are designed to track, monitor, assist and are specialized to deal with certain types of issues such as pain has been provided in the following spreadsheet.

SUMMARY OF FINDINGS

  • Montuno Software developed Dosecast, a medication management app that enables users to customize their medications and remind them when they need to refill their prescription.
  • Sanovation developed CatchMyPain and PainCompanion. CatchMyPain is a pain diary app the helps its users track their pain and establish connections with similar patients.
  • Flaredown lists all the most common triggers so that patients can track their pain. The app allows users to track activity, natural treatments, food, and mental health.
  • MyHealthTeams creates social networks for individuals who have chronic pain conditions such MyFibroTeam and MyLupusTeam. The app is integrated with social media and links its users with people who are going through the same condition.
  • Headspace is an app that helps people manage pain through at-home therapies. The therapies are a series of 10-minute meditation sessions everyday.
  • Medisafe is a medication management app that reminds users when they are supposed to take their medication. Also, the app provides doctors with real-time patient insights about the behavior of patients.
  • SkyGazer Labs developed MySymptoms, an app that tracks diet and symptoms. Users can record their diet, activities, and medication and the app can create connections between their symptoms and these factors.
  • Boston Scientific developed PainScale, a pain management mobile application that educates, tracks conditions, and gives personalized reports to its users. The platform provides physician-reviewed information and offers tips and insights on pain management.
  • Mayo Clinic Center for Innovation developed iBeatPain, an app focuses on helping teenagers suffering from chronic pain. The app incorporates home therapies into pain management.
  • WebMD developed WebMD Mobile Pain Coach, an app the enables users to locate their pain points. record triggers and symptoms, and share that information with doctors. The app also focuses on treatments, education, and exercise.

RESEARCH STRATEGY

To find the requested information, we looked through industry sites, such as Pain Doctor, Live Science, and Healthline. Here, we found lists of emerging technology companies that were developing platforms, which are designed to track, monitor, assist, and specialized to deal with certain types of health issues. We then selected 10 companies and looked at their respective websites and business platforms such as Forbes, Retail Dive, and PR Newswire to find the rest of the information required in the spreadsheet.
Part
17
of twenty-nine
Part
17

Vertical Health Tech 3

Ten companies developing platforms apps, websites, or technologies designed to track, monitor, assist, and specialized to deal with certain types of health issues are Sicklesoft, Addmedica, Adahealth, Birdhouse, Enuma, Evolvemedsys, Leading Edge Apps, Taconicsys. The requested details of these companies are compiled in rows 22-31 of the attached spreadsheet, and a summary of the information is detailed below.


VIRTA HEALTH

  • Virta Health uses machine learning to coach patients with health-based information with the aim of reversing type 2 diabetes along with other chronic metabolic diseases. It uses nutritional advice through their app, which gathers patients' health data and delivers it to a care team.
  • Additionally, this app collects patient's biomarker data such as like blood glucose, blood ketones, weight, and blood pressure to help the care team adjust the Virta Treatment regime around the individual biochemistry.

SICKLESOFT

  • Sicklesoft created clinical web applications for Adult and Pediatric Sickle Cell Centers Duke University Medical Center used to track patients. This web applications contain specialized tools that have been created to help providers monitor quality of life, neurocognitive function, depression, and pain.
  • According to the US National Library of Medicine, "SMART is a self-monitoring and management service for SCD patients and their treatment doctors."
  • Sicklesoft partners with Duke University Medical Center and the University of North Carolina at Chapel Hill.


ADDMEDICA

  • Addmedica created an app called Sickle-O-Scope. Patients with sickle cell can use this app to monitor pain and fatigue, as well as share the information with their doctor.
  • Addmedica has partnerships with Advanced Medical Solutions Group, ROVI Laboratories, Demo, Delpharm, Demo, Centre Spécialités Pharmaceutiques.


ADA HEALTH


4. BIRDHOUSE

  • Birdhouse developed the Birdhouse for Autism, which provides parents and caregivers with therapies and medications. It also helps them keep track of food, exercise, etc.
  • Additionally, it helps the caregiver or parent with a record of everything about the child's day so that they can discover triggers and be able to improve the child's care.
  • Birdhouse partners with Hope Network, Judson Center for Autism Connections, Autism Light House, Fluttering Families, Jarc, Generation Rescue, Glovinsky Center, and Autism Speaks.


5. ENUMA

  • Enuma developed a wearable picture-based scheduler for autistic children. Its intuitive interface and accessible design help create a picture-based, personalized daily schedule.
  • Enuma partnered with Xaviers Project in 2017 to launch KitKat school.


6. EVOLVEMEDSYS

  • Evolvemedsys developed smartBP, which is an app that works with Microsoft HealthVault, Apple Health and Google Fit. This app syncs data from these devices to track progress, analyze results to manage and control blood pressure.


7. LEADING EDGE APP


8. AZUMIO


9. TACONICSYS


Each company's name, website, a brief description of their technology, any existing partnerships, and all sources used can be found in rows 22-31 of the attached spreadsheet.

Part
18
of twenty-nine
Part
18

Tracking Tech 1

Companies that are developing platforms or technologies focused on tracking illnesses and community health issues include Doctors Report Illness Tracker, Health Mapper App, Flaredown, Ada, Health Gorilla, Healthkit, Parsley Health, Pain Scale, Sick Weather, and Catch My Pain.

The link to the spreadsheet is here.

1. DOCTORS REPORT ILLNESS TRACKER

  • Doctors Report Illness Tracker is an app that can alert people about illnesses around them and provide forecast.
  • It can track health and illness and use diagnostics from doctor's offices, hospitals, and clinics near the user to garner data.
  • Partner: Iron Bridge Technology Solutions
  • The link to the website is here.

2. HEALTH MAPPER APP

  • The Health Mapper App can track health conditions using symptoms, medication, and measurement.
  • The technology analyses the symptoms that occur the most using a graph. The data is then turned into health reports.
  • Partner: NHS
  • The link to the website is here.

3. FLAREDOWN

  • This is a health condition and symptom tracker app to get updates on diseases and share the information with the community within the app.
  • According to Flaredown, its is 'built by patients for patients'.
  • Partner: Ninefold and Rapid3
  • The link to the website is here.

4. ADA

  • Ada uses AI to track symptoms with the mission to personalize healthcare for everyone.
  • Ada was founded by a team of doctors, scientists, and engineers. And, it is powered by Ai to navigate appropriate care. It records symptoms and tracks diseases in communities all over the world.
  • Partner: Techniker Krankenkasse
  • The link to the website is here.

5. HEALTH GORILLA

  • Health Gorilla connects the entire healthcare ecosystem and community with a single clinical network of patients, vendors, and providers to exchange clinical data.
  • Patients can track their health data and clinicians can exchange the data across different labs, EHR, and community.
  • Partner: Apple, LabCorp, and Virta
  • The link to the website is here.

6. HEALTHKIT

  • This app allows other health apps to connect with each other (thermometer, IoT scale, Fitness app and blood pressure) to track health conditions and put it in one place for the patients and doctors.
  • Patients can find the doctor using the app. Then, use the tracking data or see the practitioners online and share it with the community.
  • Partner: ReferralNet
  • The link to the website is here.

7. PARSLEY HEALTH

  • Parsley Health app tracks diseases using whole-body approach. This app combines lifestyle, nutrition, and medical testing.
  • Patients can get to the root of their symptoms and find solutions. It tracks the symptoms and progresses so the patients can fulfill their goals.
  • Partner: Aaptiv
  • The link to the website is here.

8. PAIN SCALE

  • Health issues can be tackled with this pain tracker. It uses physician information and tracks the pain in the body using symptoms and helps in managing the treatment in one place.
  • Patient can also learn what works for them and other people in the community regarding their condition. It also provides instant report to improve the data sent to the doctor and find faster treatments.
  • Partner: My Healthy Veteran, Wings for Warriors
  • The link to the website is here.

9. SICKWEATHER

  • Sickweather is an app that uses algorithm to track illnesses.
  • It also forecasts and maps the illnesses with risk in certain locations using smartwatch.
  • Partner: Swaive Corporation, Swaive Smart Ear Thermometer
  • The link to the website is here.

10. CATCH MY PAIN

Part
19
of twenty-nine
Part
19

Tracking Tech 2


Our research team has completed rows 12-21, columns A-E in the Tracker Emerging Tech Companies Tab of the attached spreadsheet. The ten companies developing illness tracking technology and community health issues include TracknShare, Ginger.io, Healthrhythms, Mevoked, uMotif, CarePredict, CareClinic.io, Health2Sync, Sneez, and Daylio. Health Rhythms partners include Coventure, Allscripts, and Epic.

TRACKNSHARE

CINGER

  • Ginger is a technology-based mental illness tracking solution that leverages data from daily interactions, using AI, to provide insights into emotional health and access to qualified coaches and clinicians. Their website can be found here, and their partners are 40 leading academic medical centers and community health centers.

HEALTH RHYTHMS

  • HealthRhythms is the largest mental health API that uses real-time mobile measurements and continuously tracks behavioral changes linked to wellness to help measure mental health. Their website can be found here. The API serves to lower the cost for mental health screening, monitoring, and management. Partners for Health Rhythms are the National Institute of Health, Coventure, Allscripts, Epic, eClinicalWorks, NEXTGEN Healthcare, and GE Healthcare.

MEVOKED

uMOTIF

CAREPREDICT

  • CarePredict claims to detect and predict health decline in seniors. The prediction comes days ahead of clinical diagnosis to promote better care for all seniors. The company's website can be found here, and their partner is CareWorx.

CARECLINIC

HEALTH 2 SYNC

SNEEZ

DAYLIO


Part
20
of twenty-nine
Part
20

Tracking Tech 3

Ten emerging technology companies developing platforms or technologies that focus on tracking illnesses and community health issues are My Health, Symple, American Parkinson Disease Association (APDA) Symptom Tracker, Migraine Buddy, Miiskin, Imagine — Skin Condition Tracker, iHeadache, Me v PMDD Symptom Tracker, My Sugr, and Euforea. All relevant information has been documented in rows 22-31 of the attached spreadsheet, under the tab titled "Tracker Emerging Tech Companies".

EMERGING TECHNOLOGY COMPANIES

#1: MY HEALTH

  • My Health app provides patients with an easy way to track and manage their health condition using an online account. Patients will be able to access information and understand the costs of various treatments and contact the healthcare provider via their My Health account.
  • Partners: Health Pointe, Strive, and MedNow.

#2: SYMPLE

  • This app can track illnesses along with their symptoms, which can be documented in the app's "journal health". The app contains an algorithm that studies the factors involved such as medication and diet. This app is considered to be the easiest way to monitor the flow of a patient's symptoms over a period of time.
  • Partner: Scopelift.

#3: APDA SYMPTOM TRACKER — American Parkinson Disease Association

  • This app was developed to track each person's Parkinson's disease symptoms to help them better manage their care. Through the app, individuals suffering from Parkinson's disease will be able to keep track of his symptoms that include rigidity, tremors, and balance; create a report that can be shared with family and the care team; and consult the doctor for more personalized care.
  • Partner: Stanford University Medical Center.

#4: MIGRAINE BUDDY — THE MIGRAINE AND HEADACHE TRACKER

  • Migraine Buddy is a migraine tracking app that is specialized for headaches that occur in various locations. Through this app, an individual would be able to record the location of the migraine through its intuitive interface, stay updated on the weather conditions, identify migraine triggers, stay connected with family and friends, and communicate easily with healthcare professionals.
  • Partners: DukeNus, Tucker Medical, and Alexandra Health.

#5: MIISKIN

  • This app lets people keep track of melanoma by pinpointing moles. Through the app, an individual would be able to keep track of the changes of the moles on the person's body. Patients would be able to check the changes by comparing the pictures of moles over time.
  • Partner: Cadogan Clinic, Centennial Medical Care, Aleris Hamlet, and Klinika Zdybski Dermedic.

#6: IMAGINE — SKIN CONDITION TRACKER

  • Imagine is an app that helps people keep track of their skin conditions such as psoriasis and eczema. The app was developed to help people stay motivated through their treatments and measure the changes in the conditions, which can be shared with their healthcare professionals.
  • Partner: Leo Innovation Lab.

#7: iHEADACHE

  • iHeadache is a mobile app that can track a patient's headache, both acute and preventive. The app also helps track pain, disability, and other notes. A patient would be able to access a thorough report on the condition, containing detailed graphs, charts, pain analysis, symptoms, and triggers.
  • Partner: Bellaire Neurology .

#8: ME v PMDD SYMPTOM TRACKER

#9: MY SUGR

#10: MY SINUSITIS COACH — EUFOREA

  • Developed by Euforea, My Sinusitis Coach helps to improve the life of patients suffering from chronic sinusitis. The app enables patients to monitor symptoms, track medication consumption, visualize the level of control, provides unbiased information on asthma and chronic sinusitis, and the data gathered can be easily shared with doctors and family members.
  • Partners: Allergic Rhinitis and its Impact on Asthma (ARIA), Baillet Latour, CIDIC, and Voka Health Community are the non-academic partners while Ku Leuven, Universiteit Gent, Vrije Universiteit Brussel, Universiteit Antwerpen, AMC, SIAF, and Benelux Rhinologic Society are the academic partners of Euforea.
Each company's name, website, description, and existing partners have been documented in rows 22-31 of the attached spreadsheet, under the tab titled "Tracker Emerging Tech Companies"
Part
21
of twenty-nine
Part
21

Vertical Health CL 1

Virta Health is a company that offers clinically-proven treatment to safely and sustainably reverse type 2 diabetes and Headspace offers hundreds of guided meditations designed to help with everything from stress, anxiety to relationships and sleep. On the other hand, SickleSoft develops web and mobile technology based research and treatment tools for providers and people with chronic illness.

The link to the spreadsheet is here.

1. Virta Health

  • Overview: Virta Health is a company that offers clinically-proven treatment to safely and sustainably reverse type 2 diabetes and other chronic metabolic diseases without the use of medications or surgery.
  • History: It started in 2011 when Virta co-founder and CEO Sami Inkinen had prediabetes and was unsatisfied with the conventional wisdom of “exercise more and eat less”. Digging into the science of type 2 diabetes, led him to Dr. Stephen Phinney and Jeff Volek. Combining Steve and Jeff’s scientific knowledge with Sami’s technology expertise, Virta Health was then born in 2014.
  • Products: Virta Health offers Virta treatment that safely and sustainably reverses type 2 diabetes and other chronic metabolic diseases. It reduces blood sugar and A1c, eliminates costly diabetes medications and excess weight, and regain energy.
  • Funding : USD82 million
  • Claims : Virta Health claims to decrease medications. 94% of insulin users reduced or eliminated the usage after 1 year, 60% of patients reversed their type 2 diabetes after 1 year & lowered A1c, and 1.3% experienced average HbA1c reduction after 1 year.
  • Team :
    • Sami Inkinen, MS, MBA (CEO, Founder)
    • Stephen Phinney, MD, PhD (Chief Medical Officer, Founder)
    • Jeff Volek, PhD, RD (Chief Science Officer, Founder)
    • Sarah Hallberg, DO, MS (Medical Director)
  • Tech Stack: JavaScript, nginx, Python, React, PostgreSQL, Redis, Amazon EC2, Ubuntu, Amazon S3, ES6, Redux, React Native, Markdown, Swift, RabbitMQ, Flask, D3.js, Amazon DynamoDB, R, Amazon VPC, Pandas, Amazon EBS, NumPy, Matplotlib.

2. Headspace

  • Overview : Headspace was founded in 2010 by Andy Puddicombe and Rich Pierson with one mission in mind — to improve the health and happiness of the world. Headspace offers hundreds of guided meditations designed to help with everything from stress and anxiety to relationships and sleep.
  • History : Headspace was officially launched in 2010 as an events company. But, due to attendees wanting to take what they learned home with them, Andy, Rich, and their small team decided to make Andy’s techniques available online so more people could experience the benefits of meditation anytime, anywhere which led to the creation of headspace today.
  • Products : Headspace's product is an online platform that offers online sessions of guided meditation to its registered users with the goal of mindfulness. List of meditation offered includes meditation for work, kids, sleep, focus, stress, and anxiety.
  • Funding : USD75.2 million
  • Claims : Headspace claims that meditating with Headspace for three weeks may enhance compassionate behavior toward others.
  • Team :
  • Tech Stack: PHP, Apache HTTP Server, Amazon EC2, Centos, Google Analytics, Amazon CloudFront, SendGrid, Mailgun, Optimizely, G Suite.

3. Sicklesoft

  • Overview : SickleSoft is more than a technology company that enhances outpatient care by helping patients and their providers by tracking and managing medical treatments, narrow the patient-provider communication gap, and improve health outcomes. The company develops web and mobile technology based research and treatment tools for providers and people with chronic illness.
  • History : SickleSoft Inc. was founded in 2008. The company made partnership with academic medical centers such as Duke University Medical Center and the University of North Carolina at Chapel Hill. The company's product launched were SCDi and iEAT.
  • Products : Sicklesoft's product are Sickle Cell Disease (SCD) and iEAT.
A. Sickle Cell Disease (SCD) is an application to track patients' database containing demographic, clinical and research data that can be easily entered via user-friendly interfaces and can also be imported or exported via Excel files for analysis.
B. The iEAT is a software designed to capture daily clinical activities and transitions across levels of care as well as help in monitoring patients and manage treatments.
  • Funding : N/A
  • Claims : Sicklesoft claims to be leading the development of new health IT (HIT) tools designed to improve the treatment, quality of care, and self-management of chronic illnesses.
  • Team :
  • Tech Stack: IIS, Microsoft ASP.NET, Windows Server

YOUR RESEARCH TEAM APPLIED THE FOLLOWING STRATEGY:

Despite a comprehensive search, we were unable to find funding information regarding SickleSoft Inc. We commenced our research by examining SickleSoft website to find the funding information of the company. But, the only information presented on their website was company overview, product offered, claims, and company mission. Subsequently, we looked into company profile databases such as Crunchbase to find the information. However, it did the return anything significant. We also searched SickleSoft's LinkedIn, Facebook, and Twitter accounts. However, this search attempt proved to be fruitless.
As our last resort, we scanned media sources such as PRNewsWire, Forbes, BusinessInsider, etc. But no articles were found providing the funding details of SickleSoft Inc.
Part
22
of twenty-nine
Part
22

Vertical Health CL 2

Azumio, Your.MD and Enuma all make use of Google Analytics in their tech stack. Enuma is focused on educating children by offering equal learning opportunities to all children including special needs kids. Azumio provides users with healthy lifestyle services through its apps which includes fitness and food apps. Your.MD is offering people with access to basic health solutions through the use of mobile phones. Our findings can be found in the attached spreadsheet columns F — H.

FINDINGS

ENUMA

  • Enuma designs and develops learning applications that empower children including those with special needs access to educational resources.
  • The company provides several educational apps including Todo Math, Todo Telling Time, and Kid in Story and has an estimated 34 employees. Enuma was founded in 2012 in Berkeley, California.
  • The company was co-founded by Sooinn Lee and Gunho Lee when they both decided to use their expertise to help children with special needs to learn individually.

Products

  • The company offers educational apps which include Todo Math, which offers children in Pre-K through 2nd-grade practice and support in improving their math skills. Todo Telling Time is another product offered by the company which provides an interactive learning opportunity for children in kindergarten through second grade.

Funding

Team

Tech Stack

  • Google Analytics, WordFence, WordPress, Amazon EC2, Apache Web Server, Google Maps, Bootstrap.

AZUMIO

  • Azumio is a Palo Alto, California based developer of health apps, such as Fitness Buddy, Sleep Time, Glucose Buddy, Instant Heart Rate which are available on Android and iOS platforms and have over 70 million downloads.
  • The company is privately held, was founded in 2011 and has an estimated 20 employees.
  • The company was co-founded by Bojan Bostjanic and Peter Kuhar with the former acting as CEO and the latter as CTO of the company. Azumio built the first scalable healthy lifestyle services platform Argus, that provides activity and diet tracking along with a social network focused on health and fitness.

Products

  • Azumio provides food recognition software using AI image recognition technology to identify food categories, Meal IQ which helps users discover how their diets affect their BG.
  • Through its mobile apps, the company offers fitness and sleep app to help maintain the user's fitness level and improve sleep.

Funding

Team

Tech Stack

  • Early Growth Financial, AdRoll, Google DoubleClick, Yahoo! Analytics, Google Analytics, Fabric, Crashlytics, Google Tag Manager, G Suite, Mailgun, SendGrid, Google Cloud DNS, MarkMonitor, Max CDN, Google Domains, Marketo, Millenial Media, Google Compute, Google App Engine, Square, Google Cloud Messaging, AspectJ, Google Maps, Bootstrap, Salesforce, Desk.com.

YOUR.MD

  • Your.MD uses AI systems designed to understand individual situations and personal factors and discover the best available next step options to help people discover what's wrong with them.
  • Your.MD was founded in Oslo, Norway in 2013 by Harald Jellum and Matteo Berlucchi, but now headquartered in London, Great Britain. The company has an ongoing partnership with Samsung Health and the NHS.

Products

  • The company offers products such as Symptom Checker which provides customers with the best health advice after being accessed by a chatbot and a market place where customers can search for drugs, doctors and self-help and tests information.
  • Your.MD also offers the customers with a glossary of different health-related problems along with diagnosis and access to a certified medical practitioner.

Funding

Team

Tech Stack

  • Google Analytics, Bugsnag, WordPress, Tumblr, Facebook Comments, Mixpanel, Google Tag Manager, Amazon CloudFront, Amazon Route 53, Node.js, Python, Companybook, Nginx, AddThis, AngularJS, Hogan.js, Freebase, Bootstrap, Zendesk, People HR.



Part
23
of twenty-nine
Part
23

Vertical Health CL 3

SkinVision developed an app that helps people self-check for skin cancer. MoxyTech offers software that tracks and analyzes the pain associated with chronic pain. Sanovation develops innovative healthcare applications. MyHealthTeams helps connect individuals suffering from chronic pain with supportive people by creating a social network. All relevant information has been documented in columns I-L of the attached spreadsheet, under the tab titled "Vertical Health Emerging Tech CL".

VERTICAL HEALTH — COMPETITIVE LANDSCAPE

SKINVISION

  • Overview: SkinVision offers a healthcare app that helps people self-check for skin cancer. The app enables users to take pictures of skin spots and the app then assesses the risk of skin cancer in regard to the skin spots.
  • History: SkinVision was established in 2011 by dermatologists and researchers in Amsterdam. In 2013, SkinVision was clinically approved by professionals in scientific studies. In 2014, the company obtained its CE Certification. In 2017, the company's app successfully reached 1 million users across the world.
  • SkinVision has not acquired other companies nor has it been acquired by another company.
  • It was found that one of the co-founders of the company resigned from the position in 2015, after working for four years in the establishment. The company's CTO also resigned in 2015, after working for four years.
  • The company's healthcare app was launched in 2012.
  • Products: SkinVision's product is a healthcare app that offers a risk assessment for skin cancer using skin spot images that have been uploaded by the individual.
  • Funding: The company raised a total of $12.2 million in funding so far.
  • Claims: The app is expected to provide early detection of skin cancer and urges the user to consult a doctor at the right time. Studies indicate that the app has proven to detect melanoma skin cancer.
  • Team: Erik de Heus is the CEO of the company, Breght Boschker is the CTO of the company, and Walter Korteweg is the company's CFO.
  • Tech Stack: Stitch, Looker, Java, Ruby on Rails, Docker/Kubernetes, AWS (EC2, RDS, Redshift, SQS and various other), and Torch & Keras.

MOXYTECH

  • Overview: MoxyTech offers software for analyzing and tracking pain data that is associated with chronic pain. The goal of developing the software was to improve the overall quality of life for people suffering from pain.
  • History: MoxyTech is based in Ann Arbor and was established in 2014. The company's development team is made of people suffering from pain, pain researchers, and technologists.
  • MoxyTech has not been acquired not has it acquired any company.
  • The company has not had any change in leadership.
  • MoxyTech's app, GeoPain, was launched in 2018.
  • Products:
    • CLARAi is a platform designed for researchers and clinicians to help them monitor the pain levels of their patients in real-time by utilizing the patients' brain activity as a response to treatment that is still in development.
    • GeoPain is an app that is clinically proven to help users be precise and clear when describing their pain.
  • Funding: The company has received $300,000 in funding so far.
  • Claims: GeoPain is considered to be more sensitive than traditional metrics and is found to reduce the costs and risks associated with trials while engaging patients.
  • Team: Eric Maslowski is the company's co-founder, president, and CTO. Dr. Alexandre DaSilva is the company's co-founder and chief science officer, Jamie Cope is the vice president of development, and Gene Eavy is the company's executive vice president of business development.
  • Tech Stack: AWS and ClearData.

SANOVATION

  • Overview: Sanovation is a Swiss company that develops innovative healthcare applications. The company created a pain tracking app that helps patients improve their quality of life. Sanovation's partners and customers include the University of Zurich, Health Bank, Bristol-Myers Squibb, Bayer, and Zur Rose.
  • History: Sanovation was established in 2011 by Daniel Lawnickzak who was researching for an appropriate treatment for his chronic pain. Within a year, Sanovation was ranked in the top 20 companies at Venture 2012.
  • The next year (2013), the company won the startup-battle at the Startupfair. In 2014, Sanovation was selected by venturelab for the Swiss National Startup Team.
  • Sanovation has not acquired any company nor has it been acquired by another company.
  • The company's leadership team has not changed since its inception.
  • Their first product was launched in 2013.
  • Products: The main products are the Pain Companion app and Catch My Pain platform, both of which helps patients detail and record the location of their pain while tracking their symptoms.
  • Funding: Sanovation has raised a total of 350,000 CHF, which is equivalent to $355,211 USD.
  • Claims: The company claims that the healthcare apps that have been developed enable patients to live a better life.
  • Team: Roman Haag is the chairman of the board, Christoph Wolf is the vice-chairman of the board, and Christer Bergstroem and Michael Biber are members of the board.
  • Tech Stack: Health Bank, Java, Java EE, Spring MVC, Spring Roo, SQL, Hibernate, MongoDB, and Maven.

MYHEALTHTEAMS

  • Overview: MyHealthTeams help connect people suffering from chronic conditions with the best possible support by creating social networks. The company focuses on 33 chronic conditions and has developed a platform to connect people with these conditions across the world.
  • History: MyHealthTeams is a San Francisco-based company and was established in 2012 by Eric Peacock and Mary Ray. The company is an independent startup that has grown to operate with 30 different social networks and serves over 90% of addressable chronic conditions across 13 countries.
  • The company's leadership has not changed since its inception. MyHealthTeams has not acquired any company nor has it been acquired by another company.
  • The company's first app was launched in 2012.
  • Products: The company's products are social networks that allow patients to provide practical tips and perspective to each other. The list of the company's social networks are presented below —
    • MyAutismTeam, MyBCTeam, MyMSTeam, MyCrohnsandColitisTeam, MyLupusTeam, MyCOPDTeam, myRAteam, MyFibroTeam, MyEpilepsyTeam, MyPsoriasisTeam, MyEndometriosisTeam, MyParkinsonsTeam, DiabetesTeam, MyHemophiliaTeam, myALZteam, MyFoodAllergyTeam, MyChronicPainTeam, myPCOSteam, myIBSteam, MyObesityTeam, MyDepressionTeam, MyMigraineTeam, myHIVteam, MyHeartDiseaseTeam, myPHteam, MySpondylitisTeam, MyEczemaTeam, MyHyperhidrosisTeam, and MyOsteoTeam.
  • Funding: The company has raised $17.4 million in funding so far.
  • Claims: The company claims that its social networks will enable patients to experience better health outcomes.
  • Team: Eric Peacock is the CEO and co-founder of the company. Mary Ray is the COO and the co-founder of the company.
  • Tech Stack: Ruby/Rails, Ionic/Apache Cordova, MongoDB, JavaScript, CSS/Sass, jQuery, and AWS EC2.
Part
24
of twenty-nine
Part
24

Tracker Tech CL 1

Flaredown is an app that can collect clinical data report using self-reporting questions and then quantify the severity of patients condition. Health Gorilla is a platform that provides secure clinical records to connect patients and physicians with other healthcare organizations and vendors. PainScale is a smartphone app and a website suite that help patients with chronic pain to manage their pain journey.

FLAREDOWN

OVERVIEW
  • Flaredown is an app that can collect clinical data using self-report questions for multiple illnesses; the researchers then quantify the severity of the patient's condition.
  • The answers from patients report are compiled to generate a single score and Flaredown graph.
HISTORY
  • Founded in 2014 by Logan Merriam in New York. The app is 100% funded by IndieGoGo, and every fund collected by the company is used for expansion.
  • Flaredown was started by a group of patients that wanted to help others to improve their quality of health.
PRODUCTS
FUNDING
CLAIMS
  • The Symptom Tracker claims to monitor health issues using a self-reporting mobile app.
  • The patients can also find their trigger and treatment symptoms, along with effortlessly tracking their well-being.
LEADERSHIP TEAM
TECH STACK

HEALTH GORILLA

OVERVIEW
HISTORY
  • The company was founded in November 2014 by Steve Yaskin, Sergio Wagner, Andrei Zudin in Silicon Valley, California.
  • The mission of the company is to provide patients and providers with complete access to medical and health data.
PRODUCTS
  • Health Gorilla is a secure data-sharing platform for health organizations, providers, patients, and developers.
FUNDING
CLAIMS
  • Health Gorilla connects healthcare ecosystem from patients, providers by exchanging clinical data securely and make health process efficient.
  • It claims to gather all the clinical data and suggest the most appropriate care for patients. The company claims to analyze the data from over 5 million health records every day.
LEADERSHIP TEAM
TECH STACK
  • Technologies include HTML5, CSS, visualizing data using D3, WebGL.

PAIN SCALE

OVERVIEW
HISTORY
PRODUCTS
  • PainScale is a website and mobile application suite available on the Google Play Store and Apple App Store.
CLAIM
  • Pain Scale claims to have served more than 100,000 chronic pain patients; the app enables patients to manage and scale their symptoms, and get precise treatment information.
LEADERSHIP TEAM
TECH STACK
  • The platform use technologies like HTML, CSS, JavaScript, Android, and iOS.

RESEARCH STRATEGY

We were unable to find the total funding received by PainScale; below is the search strategy we applied to find the missing information.

Strategy 1) We searched through the company's official website, mobile app, and the parent company's website to identify any mentions about the funding. We were able to find details about the products and services, but no information was found regarding their funding or investment.

Strategy 2) We searched through multiple business data sites, health sites, and business sites, like Forbes and Crunchbase. Though we were able to identify mentions about the platform and its product profile, we were unable to fetch any information about their funding.

Strategy 3) We searched the funding investment data through venture capital sites, angel investment sites, and other industry funding sites like AngelList and Zirra. We were unable to find any mention about their funding history on these platforms.

We can't find the total funding investment because the data isn't available publicly and probably because Boston Scientific as their parent company may be funding the app by themselves.
Part
25
of twenty-nine
Part
25

Tracker Tech CL 2

In the "Tracker Emerging Tech Companies CL" tab of the attached project spreadsheet, we have updated columns F-H, rows 3-10 with all the requested information the health tracking companies Ginger, Mevoked, and Sneez. Ginger provides "on-demand behavioral health services" backed by machine learning and AI technologies. Mevoked "supports healthy pregnancies" by encouraging healthy behaviors and positive emotions in pregnant women. Sneez provides "real-time illness tracking" for children specific to their grade and school. We have provided a brief summary of our key findings below.

KEY FINDINGS

  • The company Ginger.io has raised a total of $28.2 million in 6 funding rounds.

RESEARCH STRATEGY

Your research team applied the following strategy. We commenced our research on the respective websites of the three companies covered in this request, taking care to comb through relevant pages of the website for information. We also made use of third-party websites such as Crunchbase and Pitchbook to retrieve information on the company's funding activities so far. Other relevant sources used are the company's LinkedIn pages where available. We have updated the project spreadsheet with all the required information.
Part
26
of twenty-nine
Part
26

Tracker Tech CL 3

We have completed a competitive analysis of companies who are creating technology surrounding tracking illnesses and community health. This analysis has been provided in rows 3-10, columns I-L of the 'Tracker Emerging Tech Companies CL' tab of the attached spreadsheet. These companies include Migraine Buddy, mySugr, CarePredict, and TracknShare App.

KEY FINDINGS

  • Migraine Buddy is a migraine tracking app that provides a fast, easy and intuitive platform for users to record their migraine experiences.
  • mySugr is an app-based, comprehensive care for diabetic patients. Made by diabetic people, the app avails diabetic patients with "the world’s best diabetes coaching," in an attempt to ease the lives of diabetic patients.
  • CarePredict operates in the healthcare space for seniors. The company seeks to transform and improve the standard of care for all seniors by "identifying patterns in the daily lives of seniors that can predict declines in their health and enable early intervention."
  • TracknShare App is a family of life management applications that allow users to track various life data on-the-go and share this data with their friends and loved ones. Trackable quantities range from autism to symptoms, habits, and moods.

RESEARCH STRATEGY

While we could pull data from company websites and social media pages of the requested companies, company directories and databases like Crunchbase, and news aggregators and industry reports like Techcrunch and PR Newswire to provide the requested information, these were limited for TracknShare App. It appears that the company is out of business, at least since 2017. We suggest so because we checked through its social media pages like Facebook and found that the last update or post was in 2017. We also checked through its blog and found that the last update was in 2017 too. We also checked through various company directories and databases but found limited information on it only on Crunchbase. Other databases like Zoominfo, Craft.co and Owler had no information on it. There was hardly any mention of the company on social media. Lastly, we could find from application stores that the developer/company was Track & Share Apps, LLC. However, there was no information on this company on business directories like Bloomberg. Hence, we could not provide information like the total amount of funding and the names and titles of the company's current leadership team.
Part
27
of twenty-nine
Part
27

GLOBAL COMBINED RESEARCH

  • The attached document contains the editable data from the entirety of the First Party Data project.
  • As a convenience, also attached is the project's spreadsheet.
Part
28
of twenty-nine
Part
28

Branded Synthesis 1

First party data is information that is collected by a company about their customer. First party data can be collected via health apps.

  • The synthesis of the 26 research projects can be viewed here.
Part
29
of twenty-nine
Part
29

Branded Synthesis 2

The 26 research projects that span the collective research on First Party Data has been synthesized into a PowerPoint.
  • The project PowerPoint can be viewed here.
Sources
Sources

From Part 02
Quotes
  • "By providing us with your personal information, you agree and consent to its transfer, processing, use and disclosure as outlined in this Privacy Statement."
  • "• name • address • telephone number • e-mail address"
Quotes
  • "GlaxoSmithKline Plc, the drug maker that manufactures over-the-counter medications such as Theraflu, is teaming up with the Massachusetts Institute of Technology to help consumers use their smartphones and tablets to better monitor their flu symptoms and share updates with family and friends on Facebook."
  • "Glaxo and MIT’s Connection Science research arm have jointly developed Flumoji, an Android app that uses crowdsourcing applications to help consumers that download the free app monitor their flu conditions or symptoms and share the data securely with Glaxo and MIT researchers and other designated Flumoji app users."
  • "The Flumoji app tracks a variety of real-time data such as flu symptoms from a user’s phone such asking how they feel and their current mood in order to detect fluctuations in a user’s activity levels, social levels and general routine, Glaxo says."
Quotes
  • "The Weather Company, an IBM Business (NYSE: IBM), announced today the renewal of its collaboration with GSK Consumer Healthcare and PHD Media Worldwide. As part of their continued relationship, Weather has introduced an enhanced Allergy Tracker, which includes increased personalization capabilities to help consumers stay one step ahead of their allergies this season. The Allergy Tracker delivers a comprehensive experience where information for managing allergies is available in the same place. "
Quotes
  • "GlaxoSmithKline (GSK) is in the midst of an exciting transformation. The global healthcare leader is completely reimagining its global marketing operations to fully harness the power of data-driven personalized marketing. Together, in partnership with Accenture, GSK is in the process of building personalized, analytics-enhanced content experiences that help healthcare professionals prescribe the right medicines to the right patients at the right time."
Quotes
  • "Last year, GSK and its brand Theraflu created a cold and flu tracker for the Russian market. The tracker used search, social and weather data to identify instances of cold and flu across each region in Russia."
  • "This tool involved content, subject matter experts and product information offered up to the user, and provided the brand with first-party data to enable better targeting of media. Kristensen stated that the tracker tool was much more powerful than the Theraflu brand website had proven previously."
Quotes
  • "The Weather Company Renews Collaboration with GSK Consumer Healthcare; Weather Unveils Enhanced Allergy Tracker with Personalized Experience to Help Consumers Better Manage Seasonal Symptoms"
Quotes
  • "Consumer genetic testing company 23andMe announced on Wednesday that GlaxoSmithKline purchased a $300 million stake in the company, allowing the pharmaceutical giant to use 23andMe’s trove of genetic data to develop new drugs — and raising new privacy concerns for consumers."
  • "The “collaboration” is a way to make “novel treatments and cures a reality,” 23andMe CEO Anne Wojcicki said in a company blog post. But, though it isn’t 23andMe’s first foray into drug discovery, the deal doesn’t seem quite so simple to some medical experts — or some of the roughly 5 million 23andMe customers who have sent off tubes of their spit in exchange for ancestry and health insights."
Quotes
  • "In a new beta program, 23andMe is asking a subset of customers if they would be willing to incorporate their lab results, prescription information and medical information with their genetic test results, according to CNBC."
  • "23andMe would be able to access patients' health data if they let the DNA-testing company connect outside medical providers using a third-party medical data network called Hum"
Quotes
  • "A new and unique smartphone app to help people with asthma manage their condition has been developed by lung experts at the Nottingham Respiratory Research Unit and the pharmaceutical company GlaxoSmithKline (GSK)."
  • "The MyAsthma app has been launched on the iTunes App Store and is available to download free of charge. The app has been devised by GSK with asthma researchers at the Nottingham Respiratory Research Unit, a world-leading centre of excellence in the field based at The University of Nottingham and Nottingham University Hospitals Trust."
  • "The MyAsthma app allows people with asthma to track and manage their condition. The app can also be used by carers who can track up to five people's conditions on their smartphone. By capturing environmental, pollen and activity data the app can allow users to record and analyse factors that seem to trigger their asthma. Users can access the clinically validated Asthma Control TestTM* (ACT) or Childhood Asthma Control Test (C-ACT)** to monitor their asthma control every 30 days. The app includes:"
From Part 03
Quotes
  • "AI& Human-Machine Collaboration IoT & Machine Intelligence Digital Design & Manufacturing Microsystems & Smart Devices Novel Printing Digital Workplace"
From Part 04
Quotes
  • "Laws such as HIPPA mandate that pharma companies can’t use first-party data to link known identifiable individuals to their medical conditions. That means Pfizer can’t obtain data that says John Doe has erectile dysfunction (ED) and use that data to serve Doe an ad for Cialis or Viagra"
  • "Sources told Digiday that pharma clients are also restricted in how they follow people around the web because many forms of retargeting can result in violations of the regulations on identifying users by their conditions. "
Quotes
  • ""Collecting customer data with consumer approval in a transparent and meaningful way, allows for richer customer experiences. Brands are leveraging this increasingly.""
  • "Show Them the Value: Adopt a scalable AI solution to provide consumers who give consent with personalized experiences."
Quotes
  • "Pfizer collaborates with Concerto HealthAI to advance precision oncology through the use of real world data."
  • "The partnership will see the companies using data from clinical practice participating in the American Society of Clinical Oncology's Cancer LinQ, which is one of the most comprehensive real-world data sets available from Concerto. "
  • "The collaboration aims to accelerate actionable patient insights for Pfizwe's precision oncology work. "
Quotes
  • "Gene-testing company 23andMe is sharing its users' data with Pfizer"
  • "And that's exactly what's happening at 23andMe. Yesterday, the personal genetics company announced a new agreement to give anonymized user data to the pharmaceutical giant Pfizer, according to the Verge. "
  • "In a press release, 23andMe said, "Researchers can now fully benefit from the largest dataset of its kind, running queries in minutes across more than 1,000 different diseases, conditions and traits. With this information researchers can identify new associations between genes and diseases and traits more quickly than ever before.""
Quotes
  • ""We can do surveys right in the app," Mark Pizzini, Pfizer's digital strategy lead, told MobiHealthNews. ""
  • "Over 20,000 people downloaded the mobile app. There’s an online Facebook community of more than 170,000 people. All of this is very positive in the pharmaceutical space where the ability to do things like this is much more regulated and controlled.""
  • "Quitter's Circle was designed based on feedback from people on what they needed in order to quit smoking. It incorporates a social feed with a curated network because Pfizer found that quitting smoking can be isolating and that family and friends were top motivators. It includes help scheduling and remembering doctor visits, because the company found that just consulting with a health care provider doubles someone's chance of quitting successfully. And it even includes a crowdfunding feature, because Pfizer found cost was a barrier to quitting for many."
  • "LivingWith includes social components to build a network of loved ones to update about treatments and progression, a dashboard to manage daily tasks and coordinate assistance from family and friends, and features to take notes and keep track of documents between doctor visits. It also includes tracking tools for mood, pain, steps, and sleep."
Quotes
  • "The App collects the personal information you choose to provide (“User Information”). "
  • "• Name • Email address • Cancer type • Your physical symptoms, feelings and mood • Your medications and dosage • Appointments • Reminders • Notes you generate • Recordings from your physician, caregiver or yourself relating to your health • Insurance information • Information from your calendar or other files on your phone • Activity information generated through the use of your connected wearable • Demographic data "
  • "If you choose to register with LivingWith, the personal information you provide as part of your registration for/opt-in to LivingWith will be transmitted to and will be used by Pfizer in accordance with the Privacy Policy posted on the Pfizer website."
  • "Data collected from your activity tracker will be sent from your activity tracker application in order to make the activity calculations that are displayed in the App. Any activity and information collected by the activity tracker is collected pursuant to their Privacy Policy."
Quotes
  • "We collect personal data you choose to provide, e.g., through registrations, applications and surveys, and in connection with your inquiries and purchases. For example, you may choose to provide your name, contact information, health, insurance and/or financial information in connection with a promotion or a patient assistance or support program. Healthcare providers may choose to provide information relating to their specialties and professional affiliations."
From Part 05
Quotes
  • "We collect and process your personal data only if you request certain services and we need your data for this purpose or if you have voluntarily given us your express consent. "
  • "You can do this, for example, by completing a registration form or sending us an email, ordering products or services, submitting inquiries to us, requesting materials or registering. Unless otherwise required by law, we will only use your personal data for the purposes for which you have given your consent."
Quotes
  • "Merck or others working for Merck may use this information to improve and/or to provide to you its products, processes, services or technologies, or as required by law or legal process. Merck or others working for Merck may collect and/or use information that identifies you personally if you choose to provide such information to Merck or those working for Merck (e.g., by using a feedback function within the Application) or otherwise give your permission for such use, or if required by law or legal process"
Quotes
  • "Yet digitalization is taking root in places other than laboratories and factory floors. It’s steadily gaining prevalence in the human resources sector as well, where it’s helping drive the transformation of the world of work. Digital HR and people analytics are key terms in this transition. Numerous companies are currently investing in programs aimed at using data to glean insights into all aspects of HR work, which can then be applied to tasks such as workforce planning, talent management and even the gradual optimization of day-to-day operations."
Quotes
  • "Does Merck have access to the Information stored on the device? No, the information stored on the device is held locally and is only available to the user."
Quotes
  • "Merck & Co. and Geisinger developed two EHR-friendly programs to boost medication adherence, reduce drug errors and help patients and providers connect on their care—and now they're taking those apps to market."
  • "The two companies plan to conduct real-world outcomes studies, with the goal of providing more scientific evidence for the programs’ use, expecting to see results in the second quarter of 2019."
Quotes
  • "One app, called Family Caregiver, enables two-way communications between patients and their care teams. The other, known as MedTrue, draws together medication data from different sources to help patients with reconciliation and adherence, creating a meds list that's vetted by both patient and provider."
Quotes
  • "StayWell announced today that it has acquired the mobile health portion of Silicon Valley-based MedHelp, which includes several consumer-facing mobile health apps."
  • "Since 2016, StayWell has been majority-owned by Healthcare Services & Solutions, a wholly owned subsidiary of global pharmaceutical giant Merck. The company offers employer-specific solutions related to several medical specialties, and has services within 85 percent of US hospitals and health systems. MedHelp's parent company, Aptus Health, is also a subsidiary of Merck."
  • "With the acquisition, StayWell will extend its reach to the 3 million users of MedHelp's platform and acquire the digital health company’s extensive portfolio of mobile health apps. These include the diabetes-focused Sugar Sense and My Diet Diary, as well as women’s health apps My Cycles and I’m Expecting."
Quotes
  • "• Actively maintain current understanding of US commercial market’s data landscape, including all 1st, 2nd and 3rd party data assets, spanning HCP, consumer, payer, patient, account, etc. • Continually scans the external environment for new valuable data assets "
From Part 10
Quotes
  • "First-party data is the data you have collected about your customers or audience, you own and manage. It can come from your own website through cookies or via your app, CRM, customer feedback, in-store beacons, purchases, contact center, point-of-sale communication, or any other information given with the consent of users (see TubeMogul article for more). It is a result of direct, trusted relationship and communication with a consumer, which makes it the most powerful."
Quotes
  • "Thus, real-time monitoring of salivary data can provide useful translational clinical applications in the detection of various human oral and systemic diseases. "
  • "Currently, there are known five major diagnostic toolboxes of saliva “Salivaomics”: proteomics (the study of proteins), transcriptomics (the study of RNAs), metabolomics (the study of metabolites), microRNA (the study of microRNAs) and microbiome (the study of microbiota) [1, 2] (Figure 1)."
  • "Recently, a great focus has been put on identification of salivary protein biomarkers for various human oral and systemic diseases such as: pancreatic cancer, Sjogren’s syndrome, oral cancer, lung cancer, orthodontically induced root resorption, etc. [2, 5]. The proteomics delivers an alternative ideal and non-invasive diagnostic tool, more sensitive, and safer for detecting the disease status. "
  • "Proteomic analysis of saliva is commonly used in the diagnostics of oral diseases as well as general health disorders such as oral candidiasis [11], oral squamous cell carcinoma (OSCC) [12], glossodynia [13], head and neck squamous cell cancer [14], Sjögren’s syndrome [15], HIV [11], autism [16], fibromyalgia [17], breast cancer [18], lung cancer, melanoma [19] or pancreatic cancer [7]. "
  • "Salivary liquid biopsy Recently, a new trend appeared to reveal emerging role of “liquid biopsy” as identification method of biomarkers in various cancers. Liquid biopsy tests are non-invasive biofluid tests (serum, urine, saliva) that detect circulating tumor cells (CTCs) and fragments of tumor DNA shed into the bloodstream by cells undergoing apoptosis or necrosis [3]."
  • "3.2. Point-of-care technologies The current knowledge of salivary biomarkers and their role in point-of-care applications highlights the need for development of more advanced technologies. As a consequence, point-of-care diagnostics is definitely approaching reality for salivary research and closely related with its translation into clinical practice [3] as it delivers information of the current status of the disease in a very fast, convenient and non-invasive way. PoCs can be successfully used for early detection and real-time monitoring of the disease [3]."
Quotes
  • "NIH supports research in technologies that use saliva to look for indicators of health conditions or diseases. Development of small, portable, and rapid processing technologies for saliva samples holds promise for faster identification of health issues and earlier access to treatment. "
  • "Technologies that will enable saliva to be used as a window into the body are being explored for their ability to detect disease and monitor our health. Efforts are underway to develop miniaturized lab-on-a-chip technology, where diagnostic tests and tools are made to be rapid, automated, and portable. Combined with saliva sample collection or cell collection (by gentle brushing of the skin surface), this technology could eliminate the need for blood sampling or mouth tissue biopsy, in many cases. "
  • "Currently available salivary diagnostic tests include various hormonal, HIV, and alcohol tests. Each test requires a small amount of saliva and produces rapid and highly accurate results. "
  • "In 2010, NIH funded two exciting new studies entitled “Salivary biomarkers for early oral cancer detection” and “Salivary proteomic and genomic biomarkers for primary Sjogren’s Syndrome.” "
Quotes
  • "Saliva tests can detect the body's glucose levels. Diabetes and oral health are connected, Messina notes. Diabetes can reduce saliva and cause dry mouth, along with other signs to discuss with your dentist, including inflamed, bleeding or reddened gums."
  • "Through saliva testing, for better or worse, employers can find out as well. Drug-testing with saliva can detect substances including cocaine, marijuana, amphetamines, ecstasy, PCP and opioid drugs. Saliva testing can also be used by clinicians to monitor many prescribed medications and ensure that drug levels in your body are therapeutic – not too high or low."
  • "Rapid oral HIV tests use saliva to quickly detect antibodies caused by a response to HIV infection. With self-test kits, users swab their mouths to collect a sample of oral fluid. Within 20 minutes or so, they have a result. "
  • "For many diseases, he says, it's being recognized as just as good, or better, than other, less accessible body fluids. Saliva tests still under development might someday detect oral cancer, periodontal disease and heart disease, he notes. It's still in experimental stages, but it's possible a spit test could predict whether a child's concussion symptoms will resolve within a few days after the injury or continue for weeks, according to a study published online Nov. 20 in JAMA Pediatrics."
Quotes
  • "02 January 2019: ERADA Technology Alliance Ltd (ERADA), pioneers of innovative, rapid diagnostic solutions for early detection of infectious diseases, have announced the imminent launch of a world first diagnostic saliva test for malaria. "
  • "The saliva-based diagnostic tool, to be marketed by ERADA as a Saliva-based Malaria Asymptomatic and Asexual Rapid Test (SMAART) for subclinical infection, is set to transform malaria detection worldwide in the fight against one of the globe's most deadly diseases. Malaria, globally kills an estimated 435,000 each year, mostly children under the age of five, mainly in Sub-Saharan Africa. 1 "
Quotes
  • "Korean researchers have developed a technology that can detect cholesterol in saliva instead of blood. This new technology is expected to be used to diagnose lipid metabolism disturbances such as hyperlipidemia. "
  • "The sensor developed by the research team takes the form of a membrane structure fixed with enzymes that combine with cholesterol. When cholesterol is attached to enzymes, electrical signals from the sensor change so that they can detect cholesterol to the level of several nanograms per milliliter of saliva. "
Quotes
  • "In the first study of its kind, researchers at Imperial College London will study the effects of DNA-personalised food choices on health outcomes for people with pre-diabetes. "
  • "Now, DnaNudge, Imperial, and Waitrose & Partners are launching a clinical trial based on a smartphone app that tells you whether any given food item is compatible with a shopper’s DNA and metabolism. "
  • "First, the shopper takes a saliva swab from inside their cheek and puts it into a cartridge which plugs into the DNA analyser, or ‘nudge box’. The analyser then scans the DNA to look for markers of being genetically prone "
Quotes
  • "a pea-sized biosensor that will measure saliva on your tongue to check glucose levels, and can supposedly be mass-produced in 3D printing at a low cost; "
  • "This one's out of Sydney, Australia, the brainchild of The iQ Group Global -- a consortium of life science and financial services companies in the biopharma field, ranging from R&D to commercialization. "
  • "On Feb. 1, they announced the Saliva Glucose Biosensor, described as a "groundbreaking" technology that would be the world's first non-invasive saliva-based glucose test. It's a small, disposal strip with a built-in pea-sized biosensor that looks a lot like a traditional glucose test strip, but is designed to sit on the tongue to measure glucose. The reading from your saliva is beamed to a proprietary digital mobile app in real-time, that will also display historic glucose levels and trends. Word is there are also data-sharing capabilities being weaved into the app. "
  • "At this point, the sensor is still in clinical studies and remains in development. You can check out their recent research results at Science Direct here. Notably, the authors explain: "
Quotes
  • "NEW DELHI: Now doctors would soon be able to detect breast and ovarian cancer through a person’s saliva. Scientists at the Indian Institute of Technology (IIT), Roorkee have developed a new non invasive method for detecting breast and ovarian cancer through salivary proteins. "
  • "Ambatipudi added that the although it is essential to clinically validate these proteins in a large cohort of subjects but the results of the present study serve as an initial step towards the development of saliva-based clinical tests. "
Quotes
  • "1. Select your raw data format & order your health report(s) of interest 2. Upload your DNA/genetic raw data 3. View your reports (Same day delivery)"
Quotes
  • "Proprietary prediction algorithms are constructed from patient – specific symptoms, lung function and biomarkers in blood and saliva. "
  • "NEPeSMO offers unique digital bio-clinical remote monitoring for prediction and prevention of lung attacks. Our products have been co-designed with patients and are bespoke to our target market. Proprietary prediction algorithms are constructed from time-series data on symptoms, lung function and biomarkers in blood/saliva supplied by patients using a bespoke App that connects wirelessly to monitoring devices. "
Quotes
  • "Prenetics owns and operates our own DNA laboratory with international quality standards and effective protocols in place for handling samples and DNA test processes. "
  • "DNA is extracted from cells in the saliva to be processed through a genotyping chip, which is a highly reliable method of DNA analysis "
  • "The information and opinions our experts provide you are based on established scientific and medical research "
Quotes
  • "Our mission is to help healthcare providers treat, heal, and inspire oral health through salivary diagnostics. "
  • "Find hidden oral pathogens that threaten your oral and systemic health. Common pathogens directly cause gum disease and may increase the risk of cardiovascular disease, diabetes, stroke and birth complications "
  • "Learn if you have HPV high-risk types associated with oral cancer "
Quotes
  • "MAVAND Solutions GmbH develops, produces and sells drug of abuse tests in combination with evaluation systems and data base management systems. The offered performance package comprehends for the first time a perfect complete solution for drug testing in the field of workplace, clinical and forensic medicine. "
  • "Rapid STAT® is a revolutionary point of collection test for the detection of drugs of abuse in oral fluid, on surfaces or for pure substance testings. Rapid STAT® combines the convenience of oral fluid collection, surface wipe testing or pure substance measurements with the sensitivity, accuracy and precision of a laboratory based test providing the results in about 6 - 8 minutes. "
Quotes
  • "Our product line includes infectious disease tests for the detection of antibodies for the HIV virus (OraQuick® In-Home HIV Test and OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test), antibodies for Hepatitis C virus (OraQuick® HCV Rapid Antibody Test) and antigens for influenza type A and type B (OraSure QuickFlu™) as well as the OraSure® HIV-1 Oral Specimen Collection Device. We also sell oral fluid testing solutions for drugs of abuse testing, including Intercept® Oral Fluid Drug Testing System and Q.E.D.® Saliva Alcohol Test. Additionally, the Company manufactures and sells several leading products for the cryosurgical removal of common and plantar warts and several other benign skin lesions. "
Quotes
  • "with 30+ at-home kits — from fertility to food sensitivity tests — ordered by you. Our tests offer simple sample collection, free shipping, and physician-reviewed results and insights sent to your device in just days. "
  • "Accurate, Physician-Reviewed Results from a CLIA-Certified Lab Actionable Data and Insights Secure Results Platform from Any Device"
Quotes
  • "THC saliva test (cannabis) Multi-drugs saliva tests • 5 drugs of abuse • one-step • no saliva manipulation • results in 10 minutes"
Quotes
  • "MX3 is about to change what’s possible for health and fitness diagnostics. This is the first simple, reliable way to measure and track hydration—anytime, anywhere. The MX3 Pro System uses a saliva sample from the tip of the tongue to take a lab-grade hydration measurement in seconds. Using the portable handheld meter, disposable test strips, and an easy-to-use app, athletes, coaches and team managers can finally measure, track, and manage hydration. With MX3 Pro, one simple device gives you control of health and performance."
Quotes
  • "At oratel diagnostics we use plant pigments to develop rapid, non-invasive and cost effective, diagnostics tests for reproductive health issues in humans and animals. "
  • "Oratel's accurate, easy-to-manufacture ENDO-TEK test can identify rapidly whether pelvic pain is due to endometriosis or something else. The assay is a swab impregnated with proprietary pigments that give color responses which correlate with the presence or absence of endometriosis. "
Quotes
  • "The first and only point-of-care saliva test for diabetes monitoring "
  • "Glucema measures sugars on saliva proteins that reflect blood glucose levels "
  • "Our reader is a first-of-its-kind, quantitative, hand-held reader that incorporates real-time test data acquisition and transfer to mobile devices and apps. "
  • "The proprietary reader phone App provides tracking and sharing of results with health care providers. "
Quotes
  • "Glucose Biosensor Systems (Greater China) Holdings, Inc. (GBSG) is a biosensor diagnostic technology company focused on commercializing the Saliva Glucose Biosensor in Mainland China, Hong Kong, Vietnam and Bangladesh. "
  • "The Saliva Glucose Biosensor is the first non-invasive, saliva-based glucose test for diabetes management that measures glucose in saliva, not blood. "
  • "With the biosensor nearby, the digital app will display glucose levels, flagging the results that need attention. "
  • "The app provides real-time comparisons with historical data, and sends data to electronic medical record or caregiver. "
Quotes
  • "In Vitro DIAGNOSTICS: Pop Test began with the creation of the world’s first saliva-based glucose test for diabetes. Its appearance is that of a lollipop that pops out of a color gauge card and uses visual interpretation. That’s where we got our name. "
  • "We achieved something that no one else has done-measuring salivary glucose down to the equivalent of blood glucose at <30mg/dl. With this accomplishment and the ability to measure small amounts of a constituent in saliva, we expanded the platform to saliva diagnostics for uric acid for gout, cholesterol for cardiovascular wellness and NASH/fatty liver disease. We also have a phone app that allows significantly finer discrimination of glucose levels. "
Quotes
  • "Our new DNA experience gives you more ways to explore your DNA Matches, connect to more precise regions, and gain insights into your personal traits. "
Quotes
  • "Experience your ancestry in a new way! Get a breakdown of your global ancestry by percentages, connect with DNA relatives and more. learn more "
  • "Learn more about your health, traits and ancestry, with a package of 125+ reports that only the 23andMe service offers. "
Quotes
  • "The saliva challenge Unique biological, chemical and physical characters prevent reliable analysis by standard diagnostic tests."
  • "Our most advanced product, allows, for the first time, early pregnancy detection by saliva. "
  • "Our approach qualifies saliva for a variety of RDT’s such as pregnancy, ovulation, H.Pylori and malaria. "
From Part 14
Quotes
  • "We’ve heard your feedback and improved the MyQuit™ App to help you successfully quit smoking. We’ll be here for every step of the journey with information, tips, and motivation exactly when you need it. "
  • "TRACK YOUR CRAVINGS Recognize, manage and keep track of your personal smoking triggers through GPS mapping. You can even edit your previously logged cravings to pinpoint the times and places where the possibility of slip-ups are high. "
  • "SUPPORT, ADVICE AND TIPS FROM SUCCESSFUL QUITTERS Hear from people who have quit smoking and are feeling great. It can really inspire you. "
  • "CUSTOMIZE YOUR QUIT Pick your quit date, select your nicotine replacement preference if you are using one, and get started. The MyQuit™ App will be there to help. "
Quotes
  • "What we collect We collect personally identifiable information (PII) that you provide to us, which is information that identifies you as an individual. We only do this when you have agreed to our request for that information. This PII may include your: • name • address • telephone number • e-mail address "
  • "How we use your PII By providing your PII, you agree that, where it is permitted by local law or where you have agreed to receiving these communications from us, we may use the information: • to respond to your requests • to improve our level of service • to improve the content of our communications and advertising • to provide you with tips, helpful information, product news and updates • to notify you of our new products and services • to seek your views on our products and services "
Quotes
  • "A new and unique smartphone app to help people with asthma manage their condition has been developed by lung experts at the Nottingham Respiratory Research Unit and the pharmaceutical company GlaxoSmithKline (GSK)."
  • "The MyAsthma app allows people with asthma to track and manage their condition. The app can also be used by carers who can track up to five people's conditions on their smartphone. By capturing environmental, pollen and activity data the app can allow users to record and analyse factors that seem to trigger their asthma. Users can access the clinically validated Asthma Control TestTM* (ACT) or Childhood Asthma Control Test (C-ACT)** to monitor their asthma control every 30 days. The app includes:"
Quotes
  • "• "Pfizer collaborates with Concerto HealthAI to advance precision oncology through the use of real world data.""
  • "• "The partnership will see the companies using data from clinical practice participating in the American Society of Clinical Oncology's Cancer LinQ, which is one of the most comprehensive real-world data sets available from Concerto. ""
  • "• "The collaboration aims to accelerate actionable patient insights for Pfizer's precision oncology work. ""
Quotes
  • "• "We can do surveys right in the app," Mark Pizzini, Pfizer's digital strategy lead, told MobiHealthNews. ""
  • "• "Over 20,000 people downloaded the mobile app. There’s an online Facebook community of more than 170,000 people. All of this is very positive in the pharmaceutical space where the ability to do things like this is much more regulated and controlled.""
  • "• "Quitter's Circle was designed based on feedback from people on what they needed in order to quit smoking. It incorporates a social feed with a curated network because Pfizer found that quitting smoking can be isolating and that family and friends were top motivators. It includes help scheduling and remembering doctor visits, because the company found that just consulting with a health care provider doubles someone's chance of quitting successfully. And it even includes a crowdfunding feature, because Pfizer found cost was a barrier to quitting for many.""
  • "• "LivingWith includes social components to build a network of loved ones to update about treatments and progression, a dashboard to manage daily tasks and coordinate assistance from family and friends, and features to take notes and keep track of documents between doctor visits. It also includes tracking tools for mood, pain, steps, and sleep.""
Quotes
  • "• The App collects the personal information you choose to provide (“User Information”). "
  • "Name • Email address • Cancer type • Your physical symptoms, feelings and mood • Your medications and dosage • Appointments • Reminders • Notes you generate • Recordings from your physician, caregiver or yourself relating to your health • Insurance information • Information from your calendar or other files on your phone • Activity information generated through the use of your connected wearable • Demographic data "
  • "Data collected from your activity tracker will be sent from your activity tracker application in order to make the activity calculations that are displayed in the App. Any activity and information collected by the activity tracker is collected pursuant to their Privacy Policy."
Quotes
  • "The MedTrue application integrates different medication data sources to assist with medication reconciliation and adherence, resulting in a patient- and healthcare team-verified medication list. The application is embedded directly within the electronic medical record (EMR) and in the healthcare provider’s workflow for optimal use of clinical and patient-reported data during patient appointments. The application is also accessible to patients from the convenience of their home. MedTrue uses SMART on FHIR so the application can be used in healthcare systems anywhere."
  • "Medication fill data from a national, leading prescription data aggregator agnostic of setting (e.g. Geisinger, non-Geisinger, inpatient, outpatient, specialty, etc.)."
  • "Patient web interface for patient-reported medication verification, changes, and adherence, accessible in the home or upon arrival at a healthcare facility"
  • "Healthcare team web interface through the patient’s EMR for point-of-care access to the patient’s validated medication list and adherence report. "
  • "“We know from prior work that about 70% of our medication lists are inaccurate, and these inaccuracies can lead to medical errors,” said Mike Evans, Vice President of Enterprise Pharmacy and Chief Pharmacy Officer for Geisinger. The “MedTrue™ application provides an interface that seeks to clean up medication lists, so patients and providers can be on the same page regarding medication use and better care decisions can be made.”"
Quotes
  • "eCare21 platform supports Remote Patient Monitoring and generates clean complaint clinical documentation for all insured patients"
Quotes
  • "eCare21 allows Medical Clinic staff to conduct timely interventions to help prevent hospital admissions and complications for patients."
  • "Managing chronic populations remotely and catching them before decompensation allows Medical Clinics to achieve: reduced cost and complexity of patient visits improved outcomes improved HCAPHS scores increased revenues"
  • "The incredibly simple and easy to use eCare21 system is designed to fit the patient's routine to help produce sustained, unassisted compliance that outperforms others. Medicare-friendly iOS & Android apps directly integrate with FDA-cleared devices to collect blood pressure, blood glucose, weight & SP02 along with self-reported medication compliance and symptoms."
  • "Provides visibility of patient progress between office visits. A real-time workflow engine identifies patients in need of attention for efficient disease management outside the office on a HIPAA-compliant platform"
  • "Clean, Compliant Documentation Improve Care Coordination Proactive Care Plan Management 24/7 Remote Patient Monitoring (RPM) Mobile App & Platform (IOS & ANDROID) 50+ Medical Devices & Sensors 100% HIPAA Compliant Improve Patient Engagement and Self-Care Engage Community of Care Secure remote monitoring by Family and Caregivers Bridges Healthcare-Homecare Gap Monitor Response Performance Data Analytics Improves Decisions"
Quotes
  • "Merck & Co. and Geisinger developed two EHR-friendly programs to boost medication adherence, reduce drug errors and help patients and providers connect on their care—and now they're taking those apps to market."
  • "The apps, MedTrue and the Family Caregiver Application, are the fruit of a six-year partnership between the Big Pharma and the hospital system. MedTrue integrates medication data from several sources, including prescription fill data, to provide a verified list of medications for each patient."
  • "Meanwhile, the Family Caregiver Application, pilot-tested with Geisinger's oncology patients, includes a shared calendar to help staffers work around a patient's personal schedule to set up procedures and medication doses. It also gathers contact information for various providers to help patients air their personal preferences and goals as their treatment progresses."
  • "The programs were designed to plug into a variety of different EHR platforms—using the SMART on FHIR set of data standards, or Substitutable Medical Applications, Reusable Technologies and Fast Healthcare Interoperability Resources—while patients and caregivers access the programs at home through a web portal."
  • "The two companies plan to conduct real-world outcomes studies, with the goal of providing more scientific evidence for the programs’ use, expecting to see results in the second quarter of 2019."
Quotes
  • "Both apps, which use SMART on FHIR specifications to incorporate data from disparate EHRs, are accessible to patients and also embed their information within providers' EHR workflows, bringing patient-reported data to the point of care. Both were also tested in clinical settings at Geisinger."
  • "The Family Caregiver application enables a calendar to meld medical and personal appointments for better care coordination, and offers a patient-managed medication scheduler based on daily activities. It gives patients information on their health care team members (specific roles, contact numbers) and offers a journal-like feature to jot notes and create narrative dialogue for patient encounters."
  • "It can help with "planning treatment appointments around important personal upcoming events and answer medical questions that the patient or caregiver may otherwise forget to ask during a scheduled appointment," he said."
  • "The MedTrue app, meanwhile, includes medication fill data from a prescription data aggregator irrespective of care setting. It uses a web-based interface for patient-reported verification, changes and adherence data, making that info accessible at home or at the health system. Caregivers can see the data within the EHR, gaining visibility into the patient's own validated meds list and help with medication nonadherence, which is a major hurdle to better population health."
Quotes
  • "• "We collect and process your personal data only if you request certain services and we need your data for this purpose or if you have voluntarily given us your express consent. ""
  • "• "You can do this, for example, by completing a registration form or sending us an email, ordering products or services, submitting inquiries to us, requesting materials or registering. Unless otherwise required by law, we will only use your personal data for the purposes for which you have given your consent.""
Quotes
  • "NEW MOBILE APP DESIGNED TO HELP LYME DISEASE PATIENTS SHOWCASED AT ‘TOP HEALTH’ TECH SPRINT HOSTED BY U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES’ (HHS) OFFICE OF THE CHIEF TECHNOLOGY OFFICER (CTO) AND PRESIDENTIAL INNOVATION FELLOWS (PIF) "
  • "Washington, D.C. and Stamford, Conn (March 4, 2019)—Global Lyme Alliance (GLA), the leading 501(c)(3) dedicated to conquering Lyme and other tick-borne diseases through research, education and awareness, and TrialX Appbakery, a revolutionary digital health platform to build patient-centric data collection apps, presented their new Lyme Symptom Tracker mobile app at the HHS’s ‘“The Opportunity Project (TOP) Health Tech Sprint” on Thursday, February 28, 2019 at The White House."
  • "The goal of the TOP Health Tech Sprint initiative was to create those digital tools that advance data-driven solutions to increase access to experimental treatments and to use the power of the crowd to solve Lyme and tick-borne diseases. GLA and TrialX’s app, Lyme Symptom Tracker, successfully addressed these two challenges. "
  • "The Lyme Symptom Tracker is the first app of its kind, designed to help Lyme disease patients easily track their symptoms and share their data with their healthcare providers. The app also integrates with TrialX’s iConnect platform to enable patients to find and connect with a clinical trial investigator near them. "
  • "TrialX used Appbakery, its do-it-yourself platform that enables one to create mobile data tracking apps for both iOS and Android, to build the Lyme Symptom Tracker. GLA provided domain expertise, assisting on the development of app requirements and obtaining user feedback. It will be recommending the live app to patients within its network. "
Quotes
  • "Find your triggers and treatments Flaredown is the most comprehensive symptom tracker ever created."
  • "Food Choose from over 200,000 foods to find sensitivities and eat healthier. Medications Track dosage, find side effects, and test out your meds. Natural Treatments Thousands of supplements and alternative interventions. Mental Health Log stress, mood, depression, anxiety and much more. Weather We auto-track temperature, humidity, precipitation, and more for you. Activity Exercise, sleep, habits, and other activities. Create your own If we don't have it, you can add it."
  • "Effortlessly track your health Flaredown will check in with you daily to make consistent tracking easy."
  • "Share your history Send a visual health history to your doctor, family, and friends."
  • "How does Flaredown use the data? Flaredown's dataset can help us find out what triggers chronic illness and how to better target treatments. We anonymize the data and share it with data scientists and researchers. You can see the exact dataset they get access to right here."
  • "Yes! Flaredown supports all conditions, here's a small selection of the thousands that our users are tracking: Undiagnosed Crohn's/UC/IBD Rheumatoid/Reactive Arthritis Lupus Erythematosus Multiple Sclerosis RSD/CRPS Sjögren's Syndrome Raynaud's Psoriasis Sarcoidosis Type 1 Diabetes Graves' Disease Hashimoto's Thyroiditis Addison's Disease Myasthenia Gravis Pernicious Anemia Celiac Disease Myositis Interstitial Cystitis Ankylosing Spondylitis ME/CFS Fibromyalgia Adrenal Fatigue Chronic Pain Chronic Migraines Ehlers-Danlos Idiopathic Hypersomnia Pyroluria Gastroparesis Endometriosis Lyme Disease POTS and Dysautonomia Hypo and Hyperthyroidism Histamine Intolerance Depression Bipolar Disorder ...and thousands more"
Quotes
  • "With the recent release of the free Doctors Report Illness Tracker, the public has another resource where they can easily check how often doctors have reported a selection of 15 diseases within a specific US zip code."
  • "“Doctorsreport.com [is] a website and mobile app that gives users access to real doctors’ report data from across the nation so they can track health risks where they happen, and when they’re happening,” Dan Shaw, CEO of Knox Spencer Associates and the service’s creator, said during an online conference call. “The information is accurate and timely, and puts the most current reliable information on current spreading or infectious health risks to common illnesses in the pockets of millions, thanks to its simple, intuitive, and trustworthy data … from doctors’ reports generated in more than 900,000 doctor’s offices across the country.”"
  • "“Whenever the physician is reporting up the chain to the payor … that data heads up the chain and that’s where our supplier grabs it and provides it,” Shaw said. “So, actually, when we get our data, it can be within 48 to 72 hours, although we compile it and maintain it until it is a sufficient size to be usable, and then we report it.”"
From Part 16
From Part 18
Quotes
  • "Doctors Report ™ Illness Tracker ™ alerts you to the Illnesses around you now which can make your family miserable. And forecasts the future. We use current diagnoses from Doctors offices, clinics and hospitals near you and around the country. Be prepared and go to your doctor. "
Quotes
  • "The app for monitoring your health conditions. Track symptoms, medication and measurements. Create, export and print health reports and charts, Share your tracking with your doctor, Set medication reminders"
Quotes
  • "Certainly, there are easier things to do in life than run a healthcare start-up, where the time, energy and money invested into making a great product matters little if the path to a large swathe of end-users (preferably within the framework of the NHS) who can test, feedback on and validate their tool is tricky to navigate."
Quotes
  • "The world's most advanced symptom tracker"
Quotes
  • "Ada Health is on a mission to bring the future of personalized care to everyone.Founded in 2011 by a team of doctors, scientists and engineers, Ada offers an AI-powered health platform that is helping millions of people around the world understand their health and navigate to the appropriate care"
  • "Our sophisticated artificial intelligence technology also supports clinical decision making and enables payers and providers to deliver quality, more effective healthcare. Ada launched globally in 2016 and has been the number 1 medical app in over 130 countries."
Quotes
  • "Ada partners with Techniker Krankenkasse, Germany's largest health insurer"
Quotes
  • "We connect the entire healthcare ecosystem on a single clinical network, empowering providers, patients, and vendors to exchange clinical data seamlessly and securely."
Quotes
  • "HealthKit is a global platform for patients and practitioners around the world that is making healthcare efficient, effective and accessible for everyone everywhere. With practitioners in over 40 different countries globally, HealthKit is one of the widest networks of practitioners and patients in the world."
Quotes
  • "The only primary care medical practice with a whole-body approach, combining nutrition, lifestyle, and cutting-edge medical testing. Find out if we're right for you."
Quotes
  • "Living Better Starts Here. Let's make pain management better for everyone through education, condition tracking, and personalized reports"
Quotes
  • "Sickweather - Sickness Forecasting & Mapping. Everyday thousands of people around the globe update social media sites like Facebook and Twitter when they (or someone close to them) get sick. Just as Doppler radar scans the skies for indicators of bad weather, Sickweather scans social networks for indicators of illness, allowing you to check for the chance of sickness as easily as you can check for the chance of rain."
Quotes
  • "We are very proud to announce our partnership with Swaive Corporation and their Swaive Smart Ear Thermometer. It marks the first time that fever data can be shared voluntarily and anonymously from an FDA approved medical device to a National map of real-time fever trends."
Quotes
  • "In order to treat pain effectively, experts recommend you keep a diary. CatchMyPain helps you to express your pain, explain it to others and observe the success of your treatment. On top of all this, you can connect with similar patients and support the fight against pain."